TEVA CANADA LIMITED v. JANSSEN INC. ET AL.
Summary of T-944-15
The following information was obtained from the Federal Court or Federal Court of Appeal websites but is NOT the official version. See links below for the court websites.
Federal Court Type: Intellectual Property - Others [Actions]
Detected Type: PMNOC - Section 8
Parties and Lawyers:| Party | Firm | Lawyer |
|---|---|---|
| JANSSEN INC | ||
| MILLENNIUM PHARMACEUTICALS INC | ||
| TEVA CANADA LTD | SMART & BIGGAR LLP | SKODYN, ANDREW |
| TEVA CANADA LTD | ||
| THE UNITED STATES OF AMERICA REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN | ||
| THE UNITED STATES OF AMERICA REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN |
| Name | Number |
|---|---|
| 2435146 | |
| 2203936 |
Patented Medicine: Bortezomib (Medicinal ingredients are based on automated analysis and should not be relied upon.)
Decisions
| Name | Date | Paragraph |
| Teva Canada Limited v. Janssen Inc. 2016 FC 318 | Mar 15, 2016 | This appeal arises from a January 26, 2016 Order by a Prothonotary, refusing to grant the Defendants’ motion for bifurcation of both (i) the Plaintiff’s damages action pursuant to section 8 of the PM(NOC) Regulations in respect of Teva’s "Bortezomib for Injection product" and (ii) the Defendants’ Counterclaim for the Plaintiff’s alleged infringement of four patents, for which the Defendants seek damages and/or an accounting of the Plaintiff’s profits. In conclusion, the Defendants have failed to demonstrate that the Prothonotary’s findings were clearly wrong either in fact or law. I thus cannot find any basis to find that there was any inappropriate exercise of her discretion, let alone anything nearing a clear case of its misuse. As a result, I decline to interfere with the Order. |
| Teva Canada Limited v. Janssen Inc. 2017 FC 437 | May 2, 2017 | Teva, after both parties had improperly filed materials under seal, brought a belated motion for a confidentiality order in respect of its information. The relief requested overreached, and greatly exceeded the scope of the evidence filed to support it. Given an opportunity to adjust its ask or provide appropriate support, Teva filed what can only be characterized as inaccurate and misleading evidence, bringing into question and irrevocably tainting the credibility and reliability of all the evidence adduced in support of its motion. As a result, the Court cannot be satisfied that the materials at issue should be treated as confidential notwithstanding the public interest in open and accessible court proceedings. For these reasons, more fully explained below, Teva’s motion is dismissed, and the material filed by the parties under seal will be placed on the open court record. The parties’ request to remove certain parts of the record is however granted, and these portions will be removed before the remaining parts of the records are unsealed. |
| Teva Canada Limited v. Janssen Inc. 2017 FC 434 | May 31, 2017 | The plaintiffs by counterclaim, Millennium Pharmaceuticals Inc., Janssen Inc., Cilag GmbH International, Cilag AG and Janssen Pharmaceutica NV, seek leave to amend their defence and counterclaim. The notice of motion was accompanied by a draft Second Amended Statement of Defence and Counterclaim including the proposed amendments. The parties agree on many of the proposed amendments. They disagree only on the proposed addition of new paragraphs 9.1 to 9.12. |
| Teva Canada Limited v. Janssen Inc. 2018 FC 754 | Jul 18, 2018 | In the Analysis section above, I have concluded that: i) the claims in issue of the 936 Patent are invalid for obviousness; ii) the claims in issue of the 146 Patent are invalid for obviousness; and iii) the processes to manufacture Teva-bortezomib and Act-bortezomib do not infringe the 706 Patent. It follows that Teva has been successful in making its case for compensation under s. 8 of the Regulations, and that Millennium and the other plaintiffs by counterclaim have been unsuccessful in their counterclaim seeking various remedies (including damages) for alleged infringement of the 936, 146 and 706 Patents. I understand that the parties have agreed that the amount of compensation to which Teva is entitled is as stated in the Minutes of Partial Settlement they executed on December 20, 2017. In my view, it is not necessary for my Judgment to address the amount of compensation because there is no disagreement on this issue. |
| Teva Canada Limited v. Janssen Inc. 2018 FC 1175 | Nov 21, 2018 | On July 18, 2018, I issued Judgment and Reasons [see 2018 FC 754] following trial of: a claim by the plaintiff, Teva, against Janssen and Millennium for compensation under s. 8 of the PMNOC Regulations for losses suffered during the time that Teva was kept off the market for its version of a drug for treating cancer that is marketed in Canada by Janssen under the name Velcade; and a counterclaim by Janssen and Millennium and the other plaintiffs by counterclaim, alleging infringement of several patents. My Judgment granted Teva’s claim, dismissed the counterclaim, and awarded costs to Teva. Because the parties were not able to agree on the amount of said costs, they provided submissions thereon. This decision addresses the amount of costs, as well as post-judgment interest. ... I will order costs payable in the amount of $1,688,660; being $850,000 in fees and $838,660 in disbursements. Post-judgment interest will run as indicated above, but no payment need be made until the appeal on the decision on the merits has been decided. |
Appeals
The following appeals were taken from decision on this proceeding: [List of appeals is based on automated analysis and should not be relied upon.]
- A-301-18 is an appeal from 2018 FC 754
Docket Summary (Google Translate to English)
() 2022-03-23 - OttawaMemorandum to file from J. Lalonde dated 23-MAR-2022 The Defendant's Exhibits (M59, M60, M90, M91, M92 and M93) were returned to Mrs Kathy Paterson from BLG LLP placed on file.
Letter from Defendant dated 20-JAN-2021 concerning the return of physical exhibits. Not received by the FC E-filing until 12-MAR-2021. received on 12-MAR-2021
Certified French language Translation of Reasons for Order and Order rendered on 02-MAY-2017 by Mireille Tabib, Prothonotary filed on 19-NOV-2020 pursuant to s. 20 of the Official Languages Act. Certificate of Translation of Order entered in J. & O. Book, volume 1470 page(s) 397 - 398 and copy placed on file.
Copy of Reasons for Judgment and Judgment dated 04-NOV-2019 rendered by The Honourable Mr. Justice Stratas The Honourable Mr. Justice Webb The Honourable Mr. Justice de Montigny placed on file. Original filed on Court File No. A-301-18
Certified French language Translation of Reasons for Order and Order rendered on 21-NOV-2018 by The Honourable Mr. Justice Locke filed on 17-JAN-2019 pursuant to s. 20 of the Official Languages Act. Certificate of Translation of Order entered in J. & O. Book, volume 1397 page(s) 190 - 191 and copy placed on file.
Certified French language Translation of Public Judgment and Reasons rendered on 18-JUL-2018 by The Honourable Mr. Justice Locke filed on 04-DEC-2018 pursuant to s. 20 of the Official Languages Act. Certificate of Translation of Judgment entered in J. & O. Book, volume 1393 page(s) 399 - 401 and copy placed on file.
Acknowledgment of Receipt received from all parties, by return email confirmation with respect to order dated November 21, 2018 placed on file on 26-NOV-2018
Order and Reasons dated 21-NOV-2018 rendered by The Honourable Mr. Justice Locke Matter considered without personal appearance The Court's decision is with regard to Order dated 18-JUL-2018 Result: THIS COURT ORDERS that: 1. The plaintiffs by counterclaim shall pay to Teva costs in the amount of $1,688,660. 2. Post-judgment interest on costs at a rate of 3%, not compounded, shall run from the date of this Order. 3. Post-judgment interest on the amount of $5 million contemplated in the Minutes of Partial Settlement shall run from July 18, 2018, at a rate of 3%, not compounded. 4. No payment shall be required until the appeal by the plaintiffs by counterclaim has been decided. Filed on 21-NOV-2018 copies sent to parties Transmittal Letters placed on file. entered in J. & O. Book, volume 1392 page(s) 476 - 477 Interlocutory Decision
Solicitor's certificate of service on behalf of Naomi Metcalfe confirming service of Doc. # 254 upon Plaintiff&Def. by Countercclaim,Former Sol, Defendants and Plaintiffs by Cou by telecopier on 16-NOV-2018 filed on 16-NOV-2018
Notice of change of solicitor on behalf of Defendants and Plaintiffs by Counterclaim filed on 16-NOV-2018
Letter from Defendant dated 02-NOV-2018 in response to the Plaintiff's letter dated 1-NOV-2018, submitting that the decision mentionned in Teva's letter does not seem to be directly relevant for the reasons listed herein. received on 02-NOV-2018
Letter from Plaintiff dated 01-NOV-2018 re: Submitting further case law in respect to costs. (Scanned to Trial Judge) received on 01-NOV-2018
Copy of Notice of Appeal (Appeal Court File No. A-301-18 ) appealing Judgment and Reasons of the Court (Locke, J.) dated 18-JUL-2018 filed in the Court of Appeal on 28-SEP-2018 on behalf of Plaintiff placed on file on 04-OCT-2018
Acknowledgment of Receipt received from all parties with respect to the correction to page 1 of the counsel sheet attached to the Reasons of Locke J. dated 16-JUL-2018 (ID 540) placed on file on 27-SEP-2018
Corrections to page 1 of the Counsel Sheet attached to the Judgment and Reasons of The Honourable Mr. Justice Locke that were dated 18-JUL-2018 received on 26-SEP-2018 Corrected page sent to the parties
Communication to the Court from the Registry dated 14-SEP-2018 re: Cost Submissions of the parties (DOCS. 245, 249 and 252) sent to Locke J.
Covering letter from Teva Canada Limited dated 11-SEP-2018 concerning Doc. Nos. 252 253 placed on file on 11-SEP-2018
Solicitor's certificate of service on behalf of Devin Doyle confirming service of DOC. No. 252 upon Defendant and of the Patentee by email on 11-SEP-2018 filed on 11-SEP-2018
Motion Record containing the following original document(s): 251 Number of copies received: 3 on behalf of Teva Canada Limited filed on 11-SEP-2018
Reply Submissions contained within a Motion Record on behalf of Teva Canada Limited in response to Direction of the Court; ID 524 - Locke, J. Submissions on costs and interest Filed on 11-SEP-2018
Affidavit of service of Kathy Paterson sworn on 04-SEP-2018 on behalf of the Defendants (Plaintiffs by Counterclaim): Janssen Inc. & Millennium Pharm confirming service of document no. 249 upon Plaintiff and the Patentee by Counterclaim (United States of America, Department of Health and Human Services) by e-mail on 04-SEP-2018 filed on 04-SEP-2018
Motion Record containing the following original document(s): 247 248 Number of copies received: 3 on behalf of the Defendants (Plaintiffs by Counterclaim): Janssen Inc. & Millennium Pharm filed on 04-SEP-2018
Affidavit of Carina de Pellegrin sworn on 04-SEP-2018 contained within a Motion Record on behalf of the Defendants (Plaintiffs by Counterclaim): Janssen Inc. & Millennium Pharm in response to Direction of the Court (Locke, J.) in ID no. 524 filed on 04-SEP-2018
Written Submissions contained within a Motion Record on behalf of the Defendants (Plaintiffs by Counterclaim): Janssen Inc & Millennium Pharma concerning Oral directions (Locke, J.) in ID. no. 524 filed on 04-SEP-2018
Book of Authorities consisting of 1 volume(s) on behalf of the Defendants (Plaintiffs by Counterclaim): Janssen Inc. & Millennium Pharm received on 04-SEP-2018
Covering letter from Plaintiff dated 17-AUG-2018 concerning docs. no 245, 246 and ID 527 placed on file on 17-AUG-2018
Solicitor's certificate of service on behalf of Devin Doyle confirming service of doc. no. 245 and ID#527 upon all parties by email on consent with paper copies to follow on 17-AUG-2018 filed on 17-AUG-2018
Book of Authorities consisting of 1 volume(s) on behalf of Plaintiff received on 17-AUG-2018
Written Submissions on behalf of Plaintiff concerning Costs filed on 17-AUG-2018
Acknowledgment of Receipt received from Mr. Doyle, Mr. Skodyn, Mr. Murphy and Ms. Courdin for Ms. Moore with respect to Direction ID#524, by email placed on file on 16-AUG-2018
Oral directions received from the Court: The Honourable Mr. Justice Locke dated 14-AUG-2018 directing that Further to the Plaintiff's letter of July 24, 2018, received on August 9, 2018, on the consent of parties, requesting a direction that the parties address the matter of whether post-judgment interest applies, and if so, at what rate, as a part of the costs submissions already contemplated in the Judgment and Reasons of July 18, 2018, as well as requesting that the page limits on the costs submissions be increased by five pages to address post- judgment interest, "The Parties' requests are granted." placed on file on 15-AUG-2018 Confirmed in writing to the party(ies)
Letter from Plaintiff dated 24-JUL-2018 With the consent of all parties seeking Directions of the Court regarding the Court's Judgment and Reasons dated July 18, 2018 received on 09-AUG-2018
sucessful transmittal report received from transmission sent by fax with respect to DOC.No. 243 & DOC. No. 244 placed on file on 18-JUL-2018
Reasons for Judgment and Judgment dated 18-JUL-2018 rendered by The Honourable Mr. Justice Locke Matter considered with personal appearance The Court's decision is with regard to Trial of the matter Result: "THIS COURT'S JUDGMENT is that: 1. The action for compensation under s. 8 of the Patented Medicines (Notice of Compliance) Regulations is granted. 2. The counterclaim is dismissed. 3. Costs will follow the event. If the parties are unable to agree on the quantum of costs, the plaintiff shall serve and file its costs submissions, if no more than 12 pags, within 30 days following the date of this decision. The defendants and plaintiffs by counterclaim shall have 15 days following receipt of the plainttif's submissions to serve and file their responding costs submissions which shall be limited to 15 pages. Thereafter, the plaintiff may, within five (5) days following receipt of responding submissions, serve and file reply costs submissions of no more that three(3) pages." Filed on 18-JUL-2018 copies sent to parties Final Decision Certificate of Judgment entered in J. & O. Book, volume 1378 page(s) 126 - 127
Reasons (CONFIDENTIAL JUDGEMENT AND REASONS) dated 18-JUL-2018 rendered by The Honourable Mr. Justice Locke Matter considered with personal appearance The Court's decision is with regard to Trial of the matter Result: see public version Filed on 18-JUL-2018 copies sent to parties Final Decision Certificate of Judgment entered in J. & O. Book, volume 1378 page(s) 124 - 125
Confirmation of successful transmission by fax on behalf of all parties with regard to the Direction and Draft Confidential Judgment and Reasons dated June 27, 2018. placed on file on 27-JUN-2018
Oral directions received from the Court: The Honourable Mr. Justice Locke dated 27-JUN-2018 directing that "THIS COURT DIRECTS that, in order to respect any concerns the parties may have for the possibility that the Judgment and Reasons may contain confidential information, the parties have until July 12, 2018, end of business hours, to inform the Court if any protions thereof should be redacted or modified in the public version thereof." Copy of Draft Confidential Judgment and Reasons transmitted. placed on file on 27-JUN-2018 Confirmed in writing to the party(ies)
Payment of Court Fees (ARV #1650) from Gowling WLG (Canada)in the amount of $2,216.67 received on May 18, 2018. placed on file on 18-MAY-2018
Payment of Court Fees (ARV #1648) received from Aitken Klee LLP in the amount of $2,216.67 received on April, 27, 2018. placed on file on 27-APR-2018
Letter from Plaintiff dated 27-APR-2018 Providing the Court with a cheque for ARV #1648 received on 27-APR-2018
Payment of Court fees (ARV #1649) from Borden Ladner & Gervais in the amount of $2,216.67 received on April 26, 2018 placed on file on 26-APR-2018
Request for payment of Court fees (ARV #1648) for the amount of $2,216.67 sent to Mr. David Aitken, Aitken Klee LLP on April 19, 2018. placed on file on 19-APR-2018
Request for payment out of Court fees (ARV #1649) for the amount of $2,216.67 sent to Mr. Mills Borden Ladner Gervais LLP on April 19, 2018. placed on file on 19-APR-2018
Request for payment of Court fees (ARV #1650) for the amount of $2,216.67, sent to Mr. Kiernan Murphy of Gowling WLG (Canada) LLP on April 19, 2018. placed on file on 19-APR-2018
Covering letter from Plaintiff dated 03-APR-2018 concerning Expert Reports and certificat of service placed on file on 04-APR-2018
Solicitor's certificate of service on behalf of Jonathan Giraldi confirming service of expert reports of Dr. Kabalka, Dr. Barrett and Dr. Anderson upon Defendant by email on 03-APR-2018 filed on 03-APR-2018
Ottawa 30-JAN-2018 BEFORE The Honourable Mr. Justice Locke Language: E Before the Court: Trial in this action Result of Hearing: Matter reserved held in Court Senior Usher: Denis Martin 30-JAN-2018 Alain Deslauriers 06-FEB-2018 Shawn Young 12-FEB-2018 Denis Martin 19-FEB-2018 Denis Gendron 20-FEB-2018 Duration per day: 30-JAN-2018 from 09:30 to 16:30 Courtroom : East Courtroom - Supreme Court of Canada Court Registrar: Marc Cossette 31-JAN-2018 from 09:30 to 13:10 Courtroom : East Courtroom - Supreme Court of Canada Court Registrar: Marc Cossette 06-FEB-2018 from 09:30 to 16:35 Courtroom : East Courtroom - Supreme Court of Canada Court Registrar: Marc Cossette 07-FEB-2018 from 09:30 to 16:15 Courtroom : East Courtroom - Supreme Court of Canada Court Registrar: Marc Cossette 08-FEB-2018 from 09:30 to 16:30 Courtroom : East Courtroom - Supreme Court of Canada Court Registrar: Marc Cossette 09-FEB-2018 from 09:30 to 11:30 Courtroom : East Courtroom - Supreme Court of Canada Court Registrar: Marc Cossette 12-FEB-2018 from 09:30 to 16:50 Courtroom : East Courtroom - Supreme Court of Canada Court Registrar: Marc Cossette 13-FEB-2018 from 09:30 to 16:35 Courtroom : East Courtroom - Supreme Court of Canada Court Registrar: Marc Cossette 14-FEB-2018 from 09:30 to 16:25 Courtroom : East Courtroom - Supreme Court of Canada Court Registrar: Marc Cossette 15-FEB-2018 from 09:30 to 16:30 Courtroom : East Courtroom - Supreme Court of Canada Court Registrar: Marc Cossette 16-FEB-2018 from 09:30 to 10:05 Courtroom : East Courtroom - Supreme Court of Canada Court Registrar: Marc Cossette 19-FEB-2018 from 09:30 to 16:30 Courtroom : East Courtroom - Supreme Court of Canada Court Registrar: Marc Cossette 20-FEB-2018 from 09:30 to 15:30 Courtroom : East Courtroom - Supreme Court of Canada Court Registrar: Marc Cossette 22-FEB-2018 from 09:30 to 16:30 Courtroom : East Courtroom - Supreme Court of Canada Court Registrar: Marc Cossette 23-FEB-2018 from 09:00 to 11:00 Courtroom : East Courtroom - Supreme Court of Canada Court Registrar: Marc Cossette 26-FEB-2018 from 09:30 to 14:50 Courtroom : East Courtroom - Supreme Court of Canada Court Registrar: Marc Cossette 27-FEB-2018 from 09:30 to 17:05 Courtroom : East Courtroom - Supreme Court of Canada Court Registrar: Marc Cossette 28-FEB-2018 from 09:30 to 16:40 Courtroom : East Courtroom - Supreme Court of Canada Court Registrar: Marc Cossette 01-MAR-2018 from 09:30 to 16:36 Courtroom : East Courtroom - Supreme Court of Canada Court Registrar: Marc Cossette 02-MAR-2018 from 09:00 to 17:30 Courtroom : East Courtroom - Supreme Court of Canada Court Registrar: Marc Cossette 07-MAR-2018 from 09:30 to 16:35 Courtroom : East Courtroom - Supreme Court of Canada Court Registrar: Marc Cossette 08-MAR-2018 from 09:30 to 16:52 Courtroom : East Courtroom - Supreme Court of Canada Court Registrar: Marc Cossette Total Duration: 22d Appearances: David Aitken 613.695.5858 representing Plaintiff Marcus Klee 613.695.5858 representing Plaintiff Bryan Norrie 613.695.5858 representing Plaintiff Jonathan Giraldi 613.695.5858 representing Plaintiff Scott Beeser 647.317.6869 representing Plaintiff Jamie Mills 613.237.5160 representing Defendant Beverley Moore 613.237.5160 representing Defendant Adrin Howard 613.237.5160 representing Defendant Chantal Saunders 613.237.5160 representing Defendant Carina De Pellegrin 613.237.5160 representing Defendant Kiernan Murphy 613.786.8675 representing Patentee Melanie Baird 416.865.2882 representing Defendant Documents filed at hearing: 229 230 Exhibits filed at hearing: M1 to M121 (Teva's exhibits have the prefix "T" and Millennium exhibits have the prefix "M") Witness(es) on behalf of Defendant Dr. Dixie-Lee Winfred Esseltine Berlin, Massachusetts on behalf of Defendant Dr. James Brodie Toronto, Ontario on behalf of Defendant Dr. Julian Adams Boston, Massachusetts on behalf of Defendant D
Book of Authorities consisting of 11 volume(s) on behalf of Defendant received on 08-MAR-2018
Closing Compendium of Millennium Defendants (11 volumes) received at hearing on 08-MAR-2018
Book of Authorities consisting of 3 volume(s) on behalf of Plaintiff received on 07-MAR-2018
Confidential Closing Compendium of Teva Canada Limited - 706 Patent Obviousness Issues (2 volumes) received at hearing on 07-MAR-2018
Confidential Closing Compendium of Teva Canada Limited - 706 Patent Infringement Issues (3 volumes) received at hearing on 07-MAR-2018
Closing Compendium of Teva Canada Limited - 146 Patent (2 volumes) received at hearing on 07-MAR-2018
Closing Compendium of Teva Canada Limited - 936 Patent 3 volumes received at hearing on 07-MAR-2018
Opening compendium of Teva Canada Limited received at hearing on 30-JAN-2018
Letter from Plaintiff dated 22-MAR-2018 attaching a USB containing the repaired hyperlinked Closing Submissions and Compendia of Teva Canada Limited regarding Canadian Patent No. 2,738,706 Obviousness. received on 22-MAR-2018
Covering letter from Defendant dated 05-MAR-2018 concerning Millennium's Read-ins, Request to Admit and Teva's responses to Requests to Admit. placed on file on 05-MAR-2018
Covering letter from Plaintiff dated 05-MAR-2018 concerning Brief of Requests to Admit of Teva and Updated Agreed Statement of Facts. placed on file on 05-MAR-2018
Solicitor's certificate of service on behalf of Jonathan Giraldi confirming service of Teva's Brief of Requests to Admit, Read-ins re Millennium, Read-ins re USA upon Defendant by email on 05-MAR-2018 filed on 05-MAR-2018
Solicitor's certificate of service on behalf of Adrian Howard confirming service of Millennium's Read-ins along with Millennium's Request to Admit and Teva's responses to the Requests to Admit upon all parties by email on 05-MAR-2018 filed on 05-MAR-2018
Amended Agreed Statement of Facts from Plaintiff on behalf of all parties filed on 05-MAR-2018
Response to request to admit on behalf of Plaintiff filed on 05-MAR-2018
Response to request to admit on behalf of Plaintiff filed on 05-MAR-2018
Request to admit on behalf of Defendant filed on 05-MAR-2018
Letter from Defendant dated 27-FEB-2018 "The Affidavit appearing at Tab 17 of MPI's motion record dated February 26, 2018, was signed but not notarized. Attached herewith, in triplicate, is a fully executed copy of Ms. Yeung's Affidavit together with proof of service. (...)" received at hearing on 27-FEB-2018
Covering letter from Millennium Pharmaceuticals, Inc., Janssen Inc., Cilag GmbH International dated 23-MAR-2018 concerning Doc. Nos. 234 235 placed on file on 23-MAR-2018
Solicitor's certificate of service on behalf of Chantal Saunders confirming service of Doc.234 upon Teva Canada Limited and The United States of America by email on 23-MAR-2018 filed on 23-MAR-2018
Sealed envelope pursuant to Justice Locke, Trial Transcript Volume 20, page 240, line 27 on behalf of Defendants/Plaintiffs by Counterclaim purporting to contain Enclosed USB of Trial Memorandum of the Defendants/Plaitiffs by Counterclaim Filed on 23-MAR-2018
Confirmation of successful transmission by fax on behalf of all parties with regard to the Oral Direction of the Honourable Justice Locke dated January 26, 2018. placed on file on 26-JAN-2018
Covering letter from Teva Canada Limited dated 21-MAR-2018 concerning enclosed USB containing the repaired hyperlinked Closing Submissions and Compendia placed on file on 21-MAR-2018
Covering letter from Teva Canada Limited dated 21-MAR-2018 concerning enclosed USB containing trial exhibits placed on file on 21-MAR-2018
Invoice # : 102996 Date: March 12, 2018 Reporter Attendance on February 26,27,28 and March 1,2,7,8. received on 12-MAR-2018
Transcript of hearing held at Ottawa on 08-MAR-2018 received on 12-MAR-2018 201 pages (including covering pages).
Transcript of hearing (IN CAMERA) held in Ottawa on March 8, 2018 received on 12-MAR-2018 13 pages (including covering pages).
Transcript of hearing (IN CAMERA) held on March 7, 2018 received on 12-MAR-2018 20 pages (including covering pages).
Transcript of hearing held at Ottawa on 07-MAR-2018 received on 12-MAR-2018 213 pages (including covering pages).
Transcript of SECOND CONFIDENTIAL LEVEL hearing held at Ottawa March 2, 2018 (Vol.20) received on 06-MAR-2018 12 pages (including covering pages).
Transcript of FIRST CONFIDENTIAL LEVEL hearing held at Ottawa March 2, 2018 (Vol. 20) received on 06-MAR-2018 29 pages (including covering pages).
Transcript of hearing held at Ottawa March 2, 2018 (Volume 20) received on 06-MAR-2018 245 pages (including covering pages).
Transcript of SECOND CONFIDENTIAL LEVEL hearing held at Ottawa March 1, 2018 (Vol. 19) received on 06-MAR-2018 53 pages (including covering pages).
Transcript of FIRST CONFIDENTIAL LEVEL hearing held at Ottawa March 1, 2018 (Vol. 19) received on 06-MAR-2018 9 pages (including covering pages).
Transcript of hearing held at Ottawa March 1, 2018 (Volume 19) received on 06-MAR-2018 198 pages (including covering pages).
Transcript of SECOND CONFIDENTIAL LEVEL hearing held at Ottawa February 28, 2018 Vol. 18 received on 06-MAR-2018 17 pages (including covering pages).
Transcript of FIRST CONFIDENTIAL LEVEL hearing held at Ottawa February 28, 2018 (Vol. 18) received on 06-MAR-2018 100 pages (including covering pages).
Transcript of hearing held at Ottawa February 28, 2018 (Volume 18) received on 06-MAR-2018 132 pages (including covering pages).
Transcript of IN-CAMERA hearing held at Ottawa February 27, 2018 (Volume 17) received on 06-MAR-2018 3 pages (including covering pages).
Transcript of hearing held at Ottawa on February 27, 2018 (Volume 17) received on 06-MAR-2018 192 pages (including covering pages).
Transcript of hearing held at Ottawa February 26, 2018 (Volume 16) received on 06-MAR-2018 161 pages (including covering pages).
Solicitor's certificate of service on behalf of Adrian Howard confirming service of Millennium's Trial Memorandum upon all parties by email on 06-MAR-2018 filed on 06-MAR-2018
Brief of Requests to Admit on behalf of Teva Canada Limited received on 05-MAR-2018
Sealed envelope pursuant to Oral Direction of Justice Locke, Trial transcript Vol. 20, page 240, line 27 on behalf of Defendants/Plaintiffs by Counterclaim purporting to contain Millennium's Trial Memorandum (doc. 232) Received on 06-MAR-2018
Trial Memorandum (CONFIDENTIAL) on behalf of Defendants / Plaintiffs by Counterclaim filed on 06-MAR-2018 1 judges' copies Sent directly to Presiding Judge
Covering letter from Plaintiff dated 06-MAR-2018 concerning Doc. Nos. 230 231 placed on file on 06-MAR-2018
Solicitor's certificate of service on behalf of Jonathan Giraldi confirming service of document 230 upon Defendant Janssen Inc. and Millennium Pharmaceuticals Inc. by email on 06-MAR-2018 confirming service document 230 upon Patentee Added, The United States of America... by email on 06-MAR-2018 confirming service document 230 upon Defendant Janssen Inc., Cilag GmbH International, Cilag AG and Janssen.. by email on 06-MAR-2018 filed on 06-MAR-2018
Closing Submissions of Teva Canada Limited Volume 1-4, Vol. 1&2 Public, Vol, 3 & 4 (contained in sealed envelopes) filed on 06-MAR-2018
Memorandum to file from Marc Cossette dated 02-MAR-2018 The Notice of Abandonment of Motion, doc. 229,was submitted in the form of a letter and served on opposing counsel in the courtroom at trial. placed on file.
Notice of abandonment of motion Motion Doc. No. 222 currently scheduled to be heard at Special Sitting on 05-MAR-2018 on behalf of Defendant filed on 02-MAR-2018
Order dated 28-FEB-2018 rendered by The Honourable Mr. Justice Locke Matter considered with personal appearance The Court's decision is with regard to Motion Doc. No. 203 Result: granted in part Filed on 01-MAR-2018 entered in J. & O. Book, volume 1361 page(s) 337 - 339 Interlocutory Decision
Transcript of hearing held at Ottawa on 23-FEB-2018 received on 27-FEB-2018 72 pages (including covering pages).
Transcript of hearing held at Ottawa on 22-FEB-2018 received on 27-FEB-2018 210 pages (including covering pages).
Transcript of hearing held at Ottawa on 20-FEB-2018 received on 27-FEB-2018 174 pages (including covering pages).
Transcript of hearing held at Ottawa on 19-FEB-2018 received on 27-FEB-2018 137 pages (including covering pages).
Solicitor's certificate of service on behalf of Carina de Pellegrin confirming service of Motion Record (Doc 226) and Book of Authorities upon all parties by email (with consent) on 26-FEB-2018 filed on 26-FEB-2018
Book of Authorities consisting of 1 volume(s) on behalf of Defendant received on 26-FEB-2018
Motion Record containing the following original document(s): 222 223 224 225 Number of copies received: 3 on behalf of Defendant filed on 26-FEB-2018
Written Representations contained within a Motion Record on behalf of Defendant concerning Motion Doc. No. 222 filed on 26-FEB-2018
Affidavit of Constance Yeung sworn on 26-FEB-2018 contained within a Motion Record on behalf of Defendant in support of Motion Doc. No. 222 filed on 26-FEB-2018
Affidavit of Mhairi Skinner sworn on 25-FEB-2018 contained within a Motion Record on behalf of Defendant in support of Motion Doc. No. 222 with Exhibits A and B filed on 26-FEB-2018
Notice of Motion contained within a Motion Record on behalf of Defendant to be heard on Monday, March 5, 2018, at a time to be set by the Court for an Order adjourning the closing arguments relating to time and effort on obviousness for Canadian Patent No. 2,203,936 and other relief filed on 26-FEB-2018
Invoice #102925 Date: February 21, 2018 Hearing held on January 30, 31, 2018. received on 23-FEB-2018
Invoice #102928 Date: February 22, 2018 Hearing held on February 6-9, 2018 received on 23-FEB-2018
Invoice# 102931 Date: February 22, 2018 Hearing held on February 12-15, 2018 received on 23-FEB-2018
Invoice #102933 Date: February 23, 2018 hearing of February 19,20,22,23 2018. received on 23-FEB-2018
Transcript of ott received on 16-FEB-2018 27 pages (including covering pages).
Transcript of hearing held at Ottawa on 15-FEB-2018 received on 20-FEB-2018 199 pages (including covering pages).
Transcript of hearing held at Ottawa on 14-FEB-2018 received on 20-FEB-2018 182 pages (including covering pages).
Transcript of hearing held at Ottawa on 13-FEB-2018 received on 20-FEB-2018 207 pages (including covering pages).
Transcript of hearing held at Ottawa on 12-FEB-2018 received on 20-FEB-2018 199 pages (including covering pages).
Order dated 19-FEB-2018 rendered by The Honourable Mr. Justice Locke Matter considered with personal appearance The Court's decision is with regard to Motion Doc. No. 212 Result: This Court orders that Millennium's motion is dismissed with costs in the cause. (Delivered from the Bench at Ottawa, Ontario on February 19, 2018) Filed on 19-FEB-2018 entered in J. & O. Book, volume 1360 page(s) 115 - 117 Interlocutory Decision
Covering letter from Plaintiff dated 14-FEB-2018 concerning Doc. No. 219 placed on file on 14-FEB-2018
Solicitor's certificate of service on behalf of Jonathan Giraldi confirming service of Responding Motion Record and Book of Authorities upon Defendant by email on 14-FEB-2018 filed on 14-FEB-2018
Book of Authorities consisting of 1 volume(s) on behalf of Plaintiff received on 14-FEB-2018
Motion Record in response to Motion Doc. No. 212 containing the following original document(s): 217 218 Number of copies received: 3 on behalf of Plaintiff filed on 14-FEB-2018
Affidavit of Dawn Trach sworn on 14-FEB-2018 contained within a Motion Record on behalf of Plaintiff in opposition to Motion Doc. No. 212 with Exhibits A,B,C,D,E filed on 14-FEB-2018
Written Representations contained within a Motion Record on behalf of Plaintiff concerning Motion Doc. No. 212 filed on 14-FEB-2018
Solicitor's certificate of service on behalf of Carina De Pellegrin confirming service of Motion Record doc. #215 and Brief of Authorities upon all parties by email with consent on 12-FEB-2018 filed at hearing on 12-FEB-2018
Brief of Authorities consisting of 1 volume(s) on behalf of Defendant received on 12-FEB-2018
Motion Record containing the following original document(s): 212 213 214 Number of copies received: 3 on behalf of Defendant filed at hearing on 12-FEB-2018
Written Representations contained within a Motion Record on behalf of Defendant concerning Motion Doc. No. 212 filed at hearing on 12-FEB-2018
Sealed envelope pursuant to the Order of Madam Prothonotary Tabib dated February 3, 2017 on behalf of Defendant purporting to contain documents #212 and 213 received at hearing on 12-FEB-2018
Affidavit of Kathy Paterson sworn on 12-FEB-2018 contained within a Motion Record on behalf of Defendant in support of Motion Doc. No. 212 with Exhibits A to D (A and B are confidential) filed at hearing on 12-FEB-2018
Notice of Motion contained within a Motion Record on behalf of Defendant returnable at trial on Friday, February 16, 2018 for an Order a. Requiring Teva to include related read-ins as a part of its proposed read-ins of Millenium; b. Refusing to allow Teva to include certain read-ins as a part of its proposed read-ins of Millenium; c. Costs of this motion, in any event of the cause; and d. Such further and other relief as this Honourable Court deems just. filed at hearing on 12-FEB-2018
Letter from Defendant dated 25-JAN-2018 "(...) Further to the Scheduling Order of December 21, 2017, Millennium takes no position on Teva's submissions or Teva's identification of the portions of the expert reports to be designated as Confidential Information or Confidential-Financial Information." received on 25-JAN-2018
Oral directions received from the Court: The Honourable Mr. Justice Locke dated 26-JAN-2018 directing that "With regard to the planitiff's request for a trial management conference to address the adequacy of the defendants' will-say statements, no such conference will be necessary. The Court is satisfied that the details provided in the defendants' will-say statements are adequate. placed on file on 26-JAN-2018 Confirmed in writing to the party(ies)
Covering letter from Defendant dated 25-JAN-2018 concerning Doc. No. 211 placed on file on 25-JAN-2018
Amended Agreed Statement of Facts from Plaintiff on behalf of all parties filed on 25-JAN-2018
Letter from Defendant dated 25-JAN-2018 "(...) We write further to the letter from counsel for Teva of today's date. The Trial Management Guidelines require that the parties exchange a brief description of the paroposed areas of testimony of fact witnesses. (...)" received on 25-JAN-2018
Letter from Plaintiff dated 25-JAN-2018 "(...) We write in respect of Will-Say Statements (...) Teva asks for an urgent trial management conference call with Justice Locke to resolve this matter. (...)" received on 25-JAN-2018
Letter from Applicant dated 22-JAN-2018 enclosing a USB key containing the reply expert reports of Dr. Bachovchin, Prof. Kabalka and Dr. Suryanarayanan received on 22-JAN-2018
Letter from Defendant dated 19-JAN-2018 Further to the Dec. 21, 2017 Order, counsel is submitting a trial calendar as well as a list of documents that it intends to tender at trial that it considers confidential. received on 19-JAN-2018
Covering letter from Plaintiff dated 19-JAN-2018 concerning Doc. No. 210 placed on file on 19-JAN-2018
Agreed Statement of Facts from Plaintiff on behalf of Teva and Millenium filed on 19-JAN-2018
Letter from Plaintiff dated 19-JAN-2018 "(...) As required by paragraph 7(e) of the Scheduling Order dated December 21, 2017, the parties wish to advise the court that the following issues still remain in dispute: (...)" received on 19-JAN-2018
Covering letter from Plaintiff dated 19-JAN-2018 concerning Doc. Nos. 207 208 209 placed on file on 19-JAN-2018
Solicitor's certificate of service on behalf of Jonathan Giraldi confirming service of doc. nos. 207, 208 and ID#409 upon Defendant by email on 19-JAN-2018 confirming service doc. no. 207, 208 and ID#409 upon the Patentee by email on 19-JAN-2018 filed on 19-JAN-2018
Book of Authorities consisting of 1 volume(s) on behalf of Plaintiff received on 19-JAN-2018
Public Version of Plaintiff's Motion Record doc. 207 (cont. docs 203, 204 and 205) - 1 volume filed on 19-JAN-2018
Confidential Motion Record submitted on behalf of the Plaintiff containing original documents: 203, 204, 205, 206 (4 volumes) filed on 19-JAN-2018
Written Representations contained within a Motion Record on behalf of Plaintiff concerning Motion in writing Doc. No. 203 filed on 19-JAN-2018
Affidavit of Tracey Burr sworn on 15-JAN-2018 contained within a Motion Record on behalf of Plaintiff in support of Motion Doc. No. 203 with Exhibits 1-4 filed on 19-JAN-2018
Affidavit of Dr. Kane Denike sworn on 17-JAN-2018 contained within a Motion Record on behalf of Plaintiff in support of Motion Doc. No. 203 with Exhibits 1 & 2 filed on 19-JAN-2018
Notice of Motion contained within a Motion Record on behalf of Plaintiff in writing to be placed before the Court in Ottawa for an Order Permitting the filing of confidential versions of certain expert reports for the Court and the filing of public versions of these reports with redactions applied as identified in Appendix "A" to this motion record and to expurgate Teva's confidential information; and 2. Such further or other relief as counsel may advise and this Honourable Court may consider just. filed on 19-JAN-2018
Letter from Counsel for the United States of America dated 15-JAN-2018 "(...) We write concerning the trail of this action currently scheduled from January 29, 2018 to March 2, 2018. We sould be very appreciative if arrangements could be made for a breakout room, with Internet access, if possible, for the duration of the trial. (...)" received on 15-JAN-2018
Confirmation of successful transmission by fax on behalf of Plaintiff and Defendants represented by Lenczner Slaght Royce Smith Griffin LLP with regard to the Directions of the Court dated January 15, 2018 placed on file on 17-JAN-2018
Acknowledgment of Receipt received from Defendant and Patentee USA with respect to the Directions of the Court dated January 15, 2018. placed on file on 15-JAN-2018
Oral directions received from the Court: The Honourable Mr. Justice Locke dated 15-JAN-2018 directing that "If the parties close the evidence during the week of February 26, I am prepared to give the parties a break of up to one week to prepare written and oral closing arguments. Closing arguments could thus be heard during the week of March 5. Please also advise the parties that it appears that, in addition to not sitting on February 1 and 2, as discussed during the TMC, it appears that we will also not sit on Monday, February 5 due to the ceremony for the new Chief Justice of the Supreme Court of Canada. I popose that we sit the full day on Friday, February 9, instead of a half-day." placed on file on 15-JAN-2018 Confirmed in writing to the party(ies)
Letter from Plaintiff dated 15-JAN-2018 "(...) The parties respectfully seek clarification on the schedule discussed at the Trial Management Conference held on December 21, 2017. (...)" received on 15-JAN-2018
Letter from Defendant dated 12-JAN-2018 "(...) We respectfully request that arrangements be made to have the following available to our group for the duration of the hearing, currently scheduled from January 29, 2018 to March 2, 2018 in Ottawa: (...)" received on 12-JAN-2018
Letter from Plaintiff dated 12-JAN-2018 "(...) We respectfully request that arrangements be made to have the following available to us for the duration of the hearing (...)" received on 12-JAN-2018
Letter from Defendant dated 05-JAN-2018 " (...) We write in response to the Order dated December 21, 2017, requiring the parties to advise the Court whether they agree to the proposal that the transcripts of examination for discovery of Dr. Plamondon and Stein be used at trial, or if they have reached agreement wi9th Teva on any other arrangements regarding the testimony of Drs. Plamondon and Stein. (...)" received on 05-JAN-2018
Letter from Plaintiff dated 22-DEC-2017 "(...) We write in response to the Order dated December 21, 2017 requiring the parties to advise the Court which of the expert report that have been filed are no longer relevant in view of the settlement of issues related to quantum. Attached to this letter is a copy of the Minutes of Partial Settlement as executed by the parties on December 20, 2017. (...)" Copy of Minutes of Partial Settlement attached. received on 22-DEC-2017
Acknowledgment of receipt on behalf of all parties with regard to the order dated December 21, 2017. placed on file on 02-JAN-2018
Letter from Defendant dated 28-DEC-2017 further to the Order dated December 21, 2017, Millenium advises regarding which trial expert reports it no longer expects to file. Scanned to Justice Locke. received on 28-DEC-2017
Order dated 21-DEC-2017 rendered by The Honourable Mr. Justice Locke Matter considered with personal appearance The Court's decision is with regard to Trial Management Conference Result: 1. Commencement of the trial postponed to Jan. 29, 2018. 2. Parties to advise the Court by Dec. 22, 2017 as to which expert reports are no longer relevant in view of settlement of issues related to quantum. 3. Defendants to advise the Court whether they agree to Teva's proposal that the transcripts of the examinations for discovery of Drs. Plamondon and Stein be used at trial or if they have reached an agreement regarding the testimony of Drs. Plamondon and Stein by Jan. 5, 2018. See Order for other deadlines. Filed on 21-DEC-2017 copies sent to parties entered in J. & O. Book, volume 1355 page(s) 229 - 232 Interlocutory Decision
Ottawa 21-DEC-2017 BEFORE The Honourable Mr. Justice Locke Language: E Before the Court: Trial Management Conference Result of Hearing: Parties advised that the quantum of damages has been settled as between the parties which will have the effect of shortening the trial. The commencement of trial as well as all the deadlines that were set for the beginning of January will be moved down by 2 weeks. Any motions will be heard on January 25, 2018. held in Court Senior Usher: Pierre Gendron Duration per day: 21-DEC-2017 from 09:30 to 10:30 Courtroom : Conference Room 1104, 11th Floor - Thomas D'Arcy McGee Bldg. - Ottawa Court Registrar: Marc Cossette Total Duration: 1h Appearances: David Aitken 613.903.5099 representing Plaintiff Marcus Klee 613.903.5100 representing Plaintiff Bryan Norrie 613.818.2315 representing Plaintiff Jonathan Giraldi 613.903.5109 representing Plaintiff Jamie Mills 613.369.4782 representing Defendant Beverly Moore 613.369.4784 representing Defendant Melanie Baird 416.865.2948 representing Defendant Kiernan Murphy 613.786.0273 representing Patentee Minutes of Hearing entered in Vol. 988 page(s) 396 - 400 Abstract of Hearing placed on file
Acknowledgment of Receipt by email received from all parties with respect to the Direction dated December 8, 2017 placed on file on 08-DEC-2017
Oral directions received from the Court: The Honourable Mr. Justice Locke dated 08-DEC-2017 directing that A trial management conference to discuss the issues raised in the parties' letters of December 7, 2017 shall be held in person in Ottawa on Thursday, December 21, 2017 at 9:30 a.m. Prior to that conference, the parties shall discuss and attempt to reach agreement on those issues. For reasons of urgency, the Court directs now that, subject to agreement otherwise between the parties, the deadline for responses to the requests to admit served on December 1, 2017 shall be December 21, 2017. placed on file on 08-DEC-2017 Confirmed in writing to the party(ies)
Letter from Defendant dated 07-DEC-2017 "(...) The purpose of this letter is to request a trial management conference to discuss the following issues: (...)" received on 07-DEC-2017
Letter from Plaintiff dated 07-DEC-2017 "(...) We write with consent of the other parties to this action. We write to address the request by the corporate defendants and plaintiffs by counterclaim ("Millennium") for a clarification with respect to the order of evidence. This letter also sets out three additional items that Teva wishes to raise in a trial management conference in advance of the trial currently scheduled to commence on January 15, 2017. (...)" received on 07-DEC-2017
Certified French language Translation of ORDER AND REASONS rendered on 02-MAY-2017 by Mireille Tabib, Prothonotary filed on 08-DEC-2017 pursuant to s. 20 of the Official Languages Act. Certificate of Translation of ORDER AND REASONS entered in J. & O. Book, volume 1353 page(s) 134 - 135 and copy placed on file.
Sealed envelope pursuant to order of 01-Dec-2017 on behalf of Teva Camada Limited purporting to contain USB Key of Exper Report of Donald Husereau Received on 07-DEC-2017
Letter from Teva Canada Limited dated 07-DEC-2017 please bring letter to attention of Justice Locke Please note on 04-Dec-17 we filed a USB containing expert reports and it has come to our attention that Volume 2 of the Report of Mr. Donald Husereau dated 10-Nov-2017 was missing Tab 1. Enclosed is a USB containing the complete copy of this Report. Copy of updated volume 2 was provided to other parties. received on 07-DEC-2017
Covering letter from Plaintiff, Defendant by Counterclaim dated 04-DEC-2017 concerning Doc. No. 200 placed on file on 04-DEC-2017
Sealed envelope pursuant to Confidentiality Order dated December 1, 2017 on behalf of Plaintiff, Defendant by Counterclaim purporting to contain USB Key containing Teva's Expert Reports Filed on 04-DEC-2017
Covering letter from Defendants, Plaintiffs by Counterclaim dated 04-DEC-2017 concerning Doc. No. 199 placed on file on 04-DEC-2017
Sealed envelope pursuant to Confidentiality Order dated December 1, 2017 on behalf of Defendants, Plaintiffs by Counterclaim purporting to contain USB Key containing expert reports, responding expert reports and reply expert reports Filed on 04-DEC-2017
confirmation by fax printout of receipt by the parties on December 1, 2017 of the order of Mr. Justice Locke dated December 1, 2017 placed on file on 01-DEC-2017
CONFIDENTIALITY ORDER dated 01-DEC-2017 rendered by The Honourable Mr. Justice Locke Matter considered without personal appearance The Court's decision is with regard to Order dated 01-DEC-2017 Result: The deadline for filing expert reports in electronic format is extended to December 4, 2017. Where, on that date, a party is required to file expert reports (including exhibits thereto) which are designated as Confidential Information or Confidential - Financial Information pursuant to the Protective Order, the party shall file the reports on a USB stick marked as confidential, and the material shall be treated as confidential, in accordance with Rule 152. For material filed under seal in electronic format in accordance with this Order, the parties are not required immediately to file public versions from which the Confidential Information or Confidential Information or Confidential - Financial Information has been redacted or removed. This Order has no application to the submission of evidence at trial. No later than January 4, 2018, any party that intends to submit as evidence any expert report which is designated as Confidential Information or Confidential - Financial Information purusant to the Protective Order shall identify all portions thereof that the party seeks to have sealed, and provide submissions justifying same. No later than January 11, 2018, any other party that opposes such identification of portions to be sealed shall provide reasoned details of such opposition. Any evidence at trial that is to be kept under seal shall be the subject of a separate order. There shall be no order as to costs. Filed on 01-DEC-2017 copies sent to parties Transmittal Letters placed on file. entered in J. & O. Book, volume 1352 page(s) 356 - 359 Interlocutory Decision
Covering letter from Plaintiff dated 01-DEC-2017 concerning Doc. Nos. 196 197 placed on file on 01-DEC-2017
Solicitor's certificate of service on behalf of Jonathan Giraldi confirming service of doc. #196 upon Defendants by email on 01-DEC-2017 confirming service doc. #196 upon Patentee Added Pursuant to s. 55(3) of the Patent Act by email on 01-DEC-2017 confirming service doc. #196 upon Defendants - Janssen Inc., Cilag GmbH, Cilag AG and Janssen Pharmaceuticals by email on 01-DEC-2017 filed on 01-DEC-2017
Trial Record on behalf of Plaintiff filed on 01-DEC-2017
Letter from Plaintiff dated 23-NOV-2017 "(...) The parties respectfully request that the Court issue a Direction permitting the parties to file under seal on December 1 any expert reports considered "Confidential Information" or "Confidential - Financial Information"." received on 23-NOV-2017
Memorandum to file from Marc Cossette dated 21-NOV-2017 The Certified Copies of the three patents which are the subject matter of this action have been placed in Annex BE. placed on file.
Letter from Defendant dated 15-NOV-2017 "(...) Please find enclosed certified copies of Canadian Patent Nos. 2,435,146, 2,738,706 and 2,203,936. received on 15-NOV-2017
Covering letter from Defendant dated 15-NOV-2017 concerning Doc. Nos. 193 194 195 placed on file on 15-NOV-2017
Consent on behalf of all parties to a rule 7 extension of time to serve and file the Amended Reply to Defence to Counterclaim filed on 15-NOV-2017
Solicitor's certificate of service on behalf of Veronica Tsou confirming service of doc. no. 193 upon all parties by electronic mail on 10-NOV-2017 filed on 10-NOV-2017
Fresh as Amended Reply to Defence to Counterclaim on behalf of Patentee added pursuant to s.55(3) of the Patent Act Filed on 10-NOV-2017
Affidavit of service of Kathy Paterson sworn on 30-OCT-2017 on behalf of Defendant confirming service of the Fresh as Amended Statement of Defence and Counterclaim upon all parties by email on 24-OCT-2017 filed on 31-OCT-2017
Letter from Defendant dated 30-OCT-2017 "It has come to our attention that the Solicitor's Certificate of Service of Beverley Moore filed October 24, 2017, contained a typo. (...)" received on 31-OCT-2017
Letter from Defendant dated 31-OCT-2017 Proposing an order to the presentation of evidence at trial with consent of Plaintiff. received on 31-OCT-2017
Acknowlegment of receipt by email on behalf of all parties with regard to the Direction of Mr. Justice Locke dated November 1, 2017. placed on file on 02-NOV-2017
Oral directions received from the Court: The Honourable Mr. Justice Locke dated 01-NOV-2017 directing that "Having read the parties' submissions on the order of evidence, the Court is not convinced that the usual order of evidence should be altered; Millennium's suggested order should be followed." placed on file on 01-NOV-2017 Confirmed in writing to the party(ies)
Covering letter from Plaintiff dated 31-OCT-2017 concerning Doc. Nos. 190 191 placed on file on 31-OCT-2017
Solicitor's certificate of service on behalf of Jonathan Giraldi confirming service of the Fresh as amended Reply and Defence to Counterclaim (Doc 190) upon all parties by email (with consent) on 31-OCT-2017 filed on 31-OCT-2017
Fresh as amended Reply and Defence to Counterclaim on behalf of Plaintiff Filed on 31-OCT-2017
Covering letter from Defendant dated 24-OCT-2017 concerning Doc. Nos. 187 188 189 placed on file on 24-OCT-2017
Solicitor's certificate of service on behalf of Beverley Moore confirming service of doc 187 upon Plaintiff and the Patentee by Counterclaim by email on 23-OCT-2017 filed on 24-OCT-2017
Consent on behalf of all parties to to the filing of the attached Fresh Amended Statement of Defence and Counterclaim filed on 24-OCT-2017
FRESH AS AMENDED Statement of Defence and Counterclaim filed on 24-OCT-2017
Acknowledgment of Receipt received from all parties by email with respect to Doc. 186 placed on file on 14-SEP-2017
Order dated 12-SEP-2017 rendered by Mireille Tabib, Prothonotary Matter considered without personal appearance The Court's decision is with regard to Letter from Plaintiff dated 28-AUG-2017 Result: 1. Paragraph 7 of the Order dated June 13, 2017 is amended as follows: a. Teva Canada Limited shall serve its expert reports in respect of non- infringement and infringement damages on or before November 10, 2017; and b. The Defendants, Plaintiffs by Counterclaim, and Patentee shall serve their expert reports, if any, in respect of Teva¿s section 8 damages and patent validity on or before November 10, 2017. 2. Paragraph 8 of the Order dated June 13, 2017 is amended such that the parties shall provide all voluntary documentary production no later than November 24, 2017, and documentary production after that date will be permitted only with leave of the Court. Filed on 12-SEP-2017 certified copies sent to parties Transmittal Letters placed on file. entered in J. & O. Book, volume 1345 page(s) 186 - 187 Interlocutory Decision
Letter from Plaintiff dated 28-AUG-2017 to be brought to Maddam Prothonotary Tabib and Justice Locke. Parties are requesting a change to the current schedule of June 13, 2017 at paragraphs 6, 7 and 8...A draft Order on consent is enclosed (scanned to CMJ and Locke, J.) received on 28-AUG-2017
Certified French language Translation of PUBLIC ORDER AND REASONS rendered on 31-MAY-2017 by The Honourable Mr. Justice Locke filed on 28-JUL-2017 pursuant to s. 20 of the Official Languages Act. Certificate of Translation of PUBLIC ORDER AND REASONS entered in J. & O. Book, volume 1341 page(s) 476 - 477 and copy placed on file.
Order dated 26-JUL-2017 rendered by Mireille Tabib, Prothonotary Matter considered with personal appearance The Court's decision is with regard to Motion Doc. No. 160 Result: granted in part Filed on 26-JUL-2017 copies sent to parties entered in J. & O. Book, volume 1341 page(s) 427 - 429 Interlocutory Decision
Order dated 26-JUL-2017 rendered by Mireille Tabib, Prothonotary Matter considered with personal appearance The Court's decision is with regard to Motion Doc. No. 155 Result: granted in part Filed on 26-JUL-2017 copies sent to parties entered in J. & O. Book, volume 1341 page(s) 424 - 426 Interlocutory Decision
Order dated 26-JUL-2017 rendered by Mireille Tabib, Prothonotary Matter considered with personal appearance The Court's decision is with regard to Motion Doc. No. 150 Result: granted in part Filed on 26-JUL-2017 copies sent to parties entered in J. & O. Book, volume 1341 page(s) 420 - 423 Interlocutory Decision
Letter from Plaintiff dated 21-JUL-2017 providing the Court with draft order for motions heard on July 11, 2017. The parties also write to advise the Cour that they have agreed to modify the timetable for the exchange of answers. received on 21-JUL-2017
Ottawa 11-JUL-2017 BEFORE Mireille Tabib, Prothonotary Language: E Before the Court: Motion Doc. No. 150 on behalf of Defendant Result of Hearing: Matter partially granted Before the Court: Motion Doc. No. 155 on behalf of Plaintiff (v. Millennium) Result of Hearing: Matter partially granted Before the Court: Motion Doc. No. 160 on behalf of Plaintiff (v. Janssen) Result of Hearing: Matter partially granted held in Court Senior Usher: Michel Deslauriers Duration per day: 11-JUL-2017 from 09:30 to 12:00 Courtroom : Conference Room 1104, 11th Floor - Thomas D'Arcy McGee Bldg. - Ottawa Court Registrar: Christen Clement Total Duration: 2.5h Appearances: Jonathan Giraldi 613-903-5109 representing Plaintiff Adrian Howard/Beverley Moore 613-369-4784 representing Defendant Comments: Counsel are to provide the Court with draft orders for each motion heard today. Parties agreed to no costs. DARS was used to record this hearing (Z006665). Recording can be released to counsel of record only. **Leave of the Court is required to release a DARS recording to any third party. Minutes of Hearing entered in Vol. 978 page(s) 188 - 199 Abstract of Hearing placed on file
Letter from Plaintiff dated 07-JUL-2017 providing a proposed agenda for hearing of the motions to compel on 11-Jul 2017 and advising that certain questions are no longwer being pursued (sent to the CMJ on 7-Jul-2017) received on 07-JUL-2017
Letter from Plaintiff dated 05-JUL-2017 providing supplemental affidavit of Dawn Trach and advising that they sought the consent of Janssen but has not yet received a response received on 05-JUL-2017
Solicitor's certificate of service on behalf of Jonathan Giraldi confirming service of Docs 179 180 upon all parties by personal service on 05-JUL-2017 filed on 05-JUL-2017
PUBLIC version of Doc. 179 filed on 05-JUL-2017
Sealed envelope pursuant to Protective Order dated May 17, 2016 and Order of June 13, 2017 on behalf of Teva in support of responding motion Doc. 168 purporting to contain Supplemental Affidavit of Dawn Trach sworn July 5, 2017 Filed on 05-JUL-2017
Covering letter from Defendant dated 29-JUN-2017 concerning Doc. Nos. 173 177 placed on file on 29-JUN-2017
Solicitor's certificate of service on behalf of Adrian Howard confirming service of doc.173 and 177 and ID.334 upon Plaintiff by personal service on 29-JUN-2017 confirming service 173, 177 and ID.334 upon Patentee by Courier on 29-JUN-2017 filed on 29-JUN-2017
Motion Record in response to Motion Doc. No. 160 containing the following original document(s): 174 175 176 Number of copies received: 3 on behalf of Defendants- Janssen Inc., Cilag GMBH International, filed on 29-JUN-2017
Sealed envelope pursuant to Protective Order dated May 17, 2016 on behalf of Defendants Janssen Inc., Cilag GMBH International purporting to contain (Exhibits 3, 4; written representations and Schedule A) Filed on 29-JUN-2017
Written Representations on behalf of Defendants - Janssen Inc., Cilag GMBH International concerning Motion Doc. No. 160 filed on 29-JUN-2017
Affidavit of Angela Malcolm sworn on 29-JUN-2017 on behalf of Defendants Janssen Inc., Cilag GMBH International in opposition to Motion Doc. No. 160 with Exhibits 1 and 2 (3, 4, Written Representations and Schedule A in a sealed Enveloppe) filed on 29-JUN-2017
Book of Authorities consisting of 1 volume(s) on behalf of Defendants - Millenium Pharmaceuticals , Inc. received on 29-JUN-2017 Sent directly to Presiding Judge
Motion Record in response to Motion Doc. No. 155 containing the following original document(s): 170 171 172 Number of copies received: 3 on behalf of Defendants- Millenium Pharmaceuticals, Inc. filed on 29-JUN-2017
Sealed envelope pursuant to Protective Order dated May 17, 2016 on behalf of Defendants - Millennium Pharmaceuticals Inc. purporting to contain (Exhibits 3, 4 and Schedule A in response to motion Doc.155) Filed on 29-JUN-2017
Written Representations on behalf of Defendants - Millennium Pharmaceuticals Inc. concerning Motion Doc. No. 155 filed on 29-JUN-2017
Affidavit of Angela Malcolm sworn on 29-JUN-2017 on behalf of Defendants - Millenium Pharmaceuticals Inc. in opposition to Motion Doc. No. 155 with Exhibits 1 and 2 (3 and 4 are confidential and Schedule A in a sealed Enveloppe) filed on 29-JUN-2017
Plubic Redacted Volume 1, 5 of 5 of Motion Record # 168. received on 29-JUN-2017
Book of Authorities consisting of 1 volume(s) on behalf of Plaintiff received on 29-JUN-2017
Covering letter from Plaintiff dated 29-JUN-2017 concerning Doc. No. 168 placed on file on 29-JUN-2017
Solicitor's certificate of service on behalf of Jonathan Giraldi confirming service of doc. 168 upon all parties by personal service on 29-JUN-2017 filed on 29-JUN-2017
Motion Record in response to Motion Doc. No. 160 containing the following original document(s): 166 167 Number of copies received: 3 on behalf of Plaintiff (CONFIDENTIAL) (5 VOLUMES) filed on 29-JUN-2017
Written Reprensations (CONFIDENTIAL) contained within a Motion Record on behalf of Plaintiff concerning Motion Doc. No. 160 filed on 29-JUN-2017
Affidavit of Dawn Trach (CONFIDENTIAL) sworn on 28-JUN-2017 contained within a Motion Record on behalf of Plaintiff in opposition to Motion Doc. No. 160 with Exhibits 1-85 filed on 29-JUN-2017
Covering letter from Plaintiff dated 22-JUN-2017 concerning Doc. Nos. 159 164 placed on file on 22-JUN-2017
Solicitor's certificate of service on behalf of Jonathan Giraldi confirming service of docs. # 159 & 164 upon Defendants by personal service on 22-JUN-2017 confirming service doc.s # 159 & 164 upon Patentee Aded pursuant to s. 55(3) of the Patent Act by personal service on 22-JUN-2017 filed on 22-JUN-2017
Book of Authorities consisting of 1 volume(s) on behalf of Plaintiff received on 22-JUN-2017
Motion Record containing the following original document(s): 160 161 162 163 Number of copies received: 3 on behalf of Plaintiff (Volumes 2 & 3 are CONFIDENTIAL) filed on 22-JUN-2017
Written Representation (PUBLIC REDACTED VOLUME 3) contained within a Motion Record on behalf of Plaintiff concerning Motion Doc. No. 160 filed on 22-JUN-2017
Written Representations (VOLUME 3 - CONFIDENTIAL) contained within a Motion Record on behalf of Plaintiff concerning Motion Doc. No. 160 filed on 22-JUN-2017
Affidavit of Dawn Trach sworn on 21-JUN-2017 contained within a Motion Record on behalf of Plaintiff in support of Motion Doc. No. 160 with Exhibits "A" to "P" (EXHIBITS "F" to "P" are CONFIDENTIAL") filed on 22-JUN-2017
Notice of Motion contained within a Motion Record on behalf of Plaintiff returnable at Special Sitting in Ottawa on 11-JUL-2017 to begin at 09:30 for 1. Requiring Jannsen to provide full answers in writing to the questions set out in Schedule A to this Motion Record; 2. Granting Teva its costs in thi smotion in any event of the cause; and 3. Granting any other remedy that this Honourable Court deems just. filed on 22-JUN-2017
Motion Record containing the following original document(s): 155 156 157 158 Number of copies received: 3 on behalf of Plaintiffs - Volume 2 & 3 are CONFIDENTIAL) filed on 22-JUN-2017
Written Representations (PUBLIC REDACTED VERSION of Volume 3) contained within a Motion Record on behalf of Plaintiff concerning Motion Doc. No. 155 filed on 22-JUN-2017
Written representations (CONFIDENTIAL) contained within a Motion Record on behalf of Plaintiff concerning Motion Doc. No. 155 filed on 22-JUN-2017
Affidavit of Dawn Trach sworn on 21-JUN-2017 contained within a Motion Record on behalf of Plaintiff in support of Motion Doc. No. 155 with Exhibits "A" to "N" (EXHIBITS F TO N ARE CONFIDENTIAL AND CONTAINED IN VOLS. 2 & 3) filed on 22-JUN-2017
Notice of Motion contained within a Motion Record on behalf of Plaintiff returnable at Special Sitting in Ottawa on 11-JUL-2017 to begin at 09:30 for 1. Requiring Mellennium to provide full answers in writing to the questions set out in Schedule A of this Motion Record; 2. Permitting Teva to conduct further discovery on the lega advice that Millennium has cited as its explanation for answers to items 407, 408 & 410; 3. Permitting Teva to conduct further discovery on questions relating to the Velcade DMF; 4. Granting Teva costs on this motion in any event of the cause; and 5. Granting any other remedy that this Honourable Court deems just. filed on 22-JUN-2017
Covering letter from Defendants/Plaintiffs by Counterclaim dated 22-JUN-2017 concerning Motion Record (doc. no. 153), Book of Authories (ID:307), Proof of Service (doc. no. 154) placed on file on 22-JUN-2017
Solicitor's certificate of service on behalf of ADRIAN HOWARD confirming service of Motion Record (doc. no. 153) and Book of Authorities (ID:307) upon Plaintiff/Defendant by Counterclaim (Teva Canada Limited) by personal service on 22-JUN-2017 confirming service Motion Record (doc. no. 153) and Book of Authorities ID:307) upon Patentee by Counterclaim (The United States of America) by courier on 22-JUN-2017 filed on 22-JUN-2017
Book of Authorities consisting of 1 volume(s) on behalf of Defendants/Plaintiffs by Counterclaim received on 22-JUN-2017
Motion Record containing the following original document(s): 150 151 152 Number of copies received: 3 on behalf of Defendants/Plaintiffs by Counterclaim (3 volumes, vol. 3 CONFIDENTIAL) filed on 22-JUN-2017
Written Representations contained within a Motion Record on behalf of Defendants/Plaintiffs by Counterclaim concerning Motion Doc. No. 150 filed on 22-JUN-2017
Affidavit of ANGELA MALCOLM sworn on 22-JUN-2017 contained within a Motion Record on behalf of Defendants/Plaintiffs by Counterclaim in support of Motion Doc. No. 150 with Exhibits "1" to "18" filed on 22-JUN-2017
Notice of Motion contained within a Motion Record on behalf of Defendants/Plaintiffs by Counterclaim returnable at special sitting in Ottawa on 11-JUL-2017 (pursuant to doc.149) for an Order a. Requiring Teva to answer the questions from the continued examination for discovery of Dr. Ikeda dated May 16-17, 2017, as listed in the chart attached as Schedule "A" to the written representations, by July 28, 2017; b. Requiring a representative of Teva to re-attend on discovery, at the expense of Tevam to answer all relevant follow-up questions resulting from the answers already provided by Treva and the questions ordered to be answered herein; c. Requiring Teva to provide unredacted copies of TEVA0283 and TEVA0284; d. Costs of this motion, in any event of the cause; and e. Such further and other relief as this Honourable Court deems just. filed on 22-JUN-2017
Acknowledgment of Receipt received from all parties by email with respect to Doc.149 placed on file on 14-JUN-2017
Order dated 13-JUN-2017 rendered by Mireille Tabib, Prothonotary Matter considered without personal appearance The Court's decision is with regard to Letter from Plaintiff dated 06-JUN-2017 Result: A timetable is set. See Order for details Filed on 14-JUN-2017 copies sent to parties entered in J. & O. Book, volume 1337 page(s) 98 - 103 Interlocutory Decision
Ottawa 12-JUN-2017 BEFORE Mireille Tabib, Prothonotary Language: E Before the Court: Case Management Conference to discuss the proposed schedule and issues regarding the refusal to produce batch records to Janssen/Millennium Result of Hearing: The Court is prepared to sign off on the joint proposed draft scheduling order. If parties cannot resolve the issues regarding the production of batch records, the Court expects parties to file sufficient materials (submissions or a motion record) so that it can be addressed at the hearing on July 11, 2017, and set down any motion, if necessary. held in chambers by way of Conference Call Duration per day: 12-JUN-2017 from 03:30 to 03:45 Courtroom : Judge's Chambers - Ottawa Court Registrar: Christen Clement Total Duration: 15min Appearances: B. Norrie/J. Geraldi 613-903-5107 representing Plaintiff A. Howard/B. Moore 613-369-4784 representing Defendant K. Murphy 613-786-0273 representing USA-Patentee by statute Minutes of Hearing entered in Vol. 976 page(s) 338 - 341 Abstract of Hearing placed on file
Letter from Plaintiff dated 06-JUN-2017 on consent, requesting the issuance of the attached Order, which is a consolidated schedule, as requested by the Court at the previous case conference... received on 06-JUN-2017
Acknowledgment of Receipt received from all parties by email with respect to Doc.148 placed on file on 31-MAY-2017
Reasons for Order and Order(PUBLIC) dated 31-MAY-2017 rendered by The Honourable Mr. Justice Locke Matter considered with personal appearance The Court's decision is with regard to Motion Doc. No. 119 Result: 1. The disputed aspect of the motion by the plaintiffs by counterclaim to amend their Amended Statement of Defence and Counterclaim is dismissed. 2. The plaintiffs by counterclaim may serve and file, within three days following the date of this Order, a Second Amended Statement of Defence and Counterclaim including the other amendments that have been agreed to between the parties. 3. Teva Canada Limited may serve and file, within seven days following service of the Second Amended Statement of Defence and Counterclaim, a Second Amended Reply and Defence to Counterclaim. 4. The plaintiffs by counterclaim shall pay costs of the motion in the amount of $1,000 to Teva Canada Limited. Filed on 31-MAY-2017 certified copies sent to parties (*Identical to the Confidential Order and Reasons issued May 2, 2017*) Transmittal Letters placed on file. Interlocutory Decision Copy of Reasons for Order and Order entered in J. & O. Book, volume 1336 page(s) 7 - 19
Solicitor's certificate of service on behalf of Marc Crandall confirming service of Doc. # 146 upon Plaintiff and Defendant by Counterclaim by e-mail on 23-MAY-2017 confirming service Doc. # 146 upon Defendants and the Plaitiffs by Counterclaim by e-mail on 23-MAY-2017 confirming service doc. # 146 upon Defendants and Plaintiffs by Counterclaim by e-mail on 23-MAY-2017 filed on 23-MAY-2017
SECOND AMENDED REPLY TO DEFENCE TO COUNTERCLAIM on behalf of the Patentee Added pursuant to s. 55(3) of the Patent Act filed on 23-MAY-2017
Covering letter from Plaintiff dated 23-MAY-2017 concerning Doc. Nos. 145 placed on file on 23-MAY-2017
Solicitor's certificate of service on behalf of Adrian Howard confirming service of Doc. No. 144 upon Defendant by email on 23-MAY-2017 filed on 23-MAY-2017
Further Amended (second)Reply to Defence to Counterclaim of Janssen Inc. and Millennium filed on 23-MAY-2017
Oral directions received from the Court: The Honourable Mr. Justice Locke dated 17-MAY-2017 directing that "In view of the order of Prothonotary Mireille Tabib dated May 2, 2017, the parties shall have until Wednesday, May 24, 2017, to convince the Court that portions of my confidential order and reasons should remain hidden from the public, failing which the entire order and reasons shall be made available to the public." placed on file on 17-MAY-2017
Covering letter from Plaintiff dated 12-MAY-2017 concerning Doc. No. 142 placed on file on 12-MAY-2017
Solicitor's certificate of service on behalf of Jonathan Giraldi confirming service of Doc. 142 upon all parties by email on 12-MAY-2017 filed on 12-MAY-2017
Amended Second Reply and Defence to Counterclaim on behalf of Plaintiff Filed on 12-MAY-2017
Covering letter from Defendant dated 05-MAY-2017 concerning Doc. No. 140 placed on file on 05-MAY-2017
Solicitor's certificate of service on behalf of Adrian Howard confirming service of Doc. 140 upon all parties by email on 05-MAY-2017 filed on 05-MAY-2017
Amended Second Statement of Defence and Counterclaim filed on 05-MAY-2017
Memorandum to file from CMT-Ottawa dated 04-MAY-2017 In accordance with the Court's (Tabib, P.) Order and Reasons dated May 2, 2017, the Registry has removed the required pages from Janssen and Teva's motion records and the remaining portions have been unsealed and placed on the public record. placed on file.
Acknowledgment of Receipt received from all parties by email with respect to Doc. 139 placed on file on 03-MAY-2017
Reasons for Order and Order dated 02-MAY-2017 rendered by Mireille Tabib, Prothonotary Matter considered with personal appearance The Court's decision is with regard to Motion Doc. No. 129 Result: dismissed 1. The Registry shall remove the following pages from the parties' materials filed on Janssen's motion to amend; -the pages under tab 16 volume 3 of Janssen's Motion Record. -Pages 0124 to 0142, inclusive, of Teva's Motion Record. 2. Teva's motion to maintain the confidentiality of the materials filed under seal is otherwise dismissed, and the Registry shall unseal and place on the public record the remaining portions of the parties' materials. Filed on 02-MAY-2017 certified copies sent to parties Transmittal Letters placed on file. Interlocutory Decision Certificate of Order entered in J. & O. Book, volume 1333 page(s) 305 - 306
Acknowledgment of Receipt received from all parties with respect to the Reasons and Order Confidential (Doc.#138) placed on file on 02-MAY-2017
Reasons and Order Confidential dated 02-MAY-2017 rendered by The Honourable Mr. Justice Locke Matter considered with personal appearance The Court's decision is with regard to Motion Doc. No. 119 Result: dismissed Filed on 02-MAY-2017 certified copies sent to parties Interlocutory Decision Copy of Reasons for and Order Confidential entered in J. & O. Book, volume 1333 page(s) 202 - 214
Solicitor's certificate of service on behalf of Adrian Howard confirming service of the letter ID#278 upon all parties by email on 27-APR-2017 filed on 27-APR-2017
Letter from Defendants, Janssen Inc. and Millennium Pharmaceuticals, Inc. & others dated 27-APR-2017 in response to the Court's direction dated April 25, 2017 with attachments received on 27-APR-2017
Covering letter from Plaintiff dated 27-APR-2017 concerning Doc. Nos. 135 136 placed on file on 27-APR-2017
Affidavit of service of Solicitor's Certificate of Service sworn on 27-APR-2017 on behalf of Plaintiff confirming service of of document #135 upon all parties by email on consent on 27-APR-2017 filed on 27-APR-2017
Affidavit of Dr. Glenn Ikeda sworn on 27-APR-2017 on behalf of Plaintiff, Eva Canada Limited pursuant to Oral Directions of the Court, dated April 25, 2017 with Exhibits "1" to "5" filed on 27-APR-2017
Oral directions received from the Court: Mireille Tabib, Prothonotary dated 25-APR-2017 directing that 'The Court has reviewed the affidavit of Glenn Ikeda filed April 20, 2017 and has concerns regarding the facts asserted at paragraphs 5 and 6 of that affidavit. From experience in pharmaceutical litigation, it is the Court's understanding that for medicines marketed in European countries, the the identity and location of a drug product's manufacturer is required to be disclosed and made available to the public as part of the product's Patient Information Leaflet, or Package Leaflet. In the interest of ensuring that the Court's decisions are not based on incomplete or misleading information, both parties are asked to provide the Court with evidence setting out their information knowledge or belief as to whether Teva bortezomib is marketed in any European Union countries, and if so, whether the identity of its manufacturer is disclosed in the Package Leaflet(s). The parties may file such complementary written submissions as may be required in light of new evidence. The parties' evidence and submissions should be served and filed by noon on Thursday April 27, 2017.' placed on file on 25-APR-2017 Confirmed in writing to the party(ies)
Letter from Plaintiff dated 20-APR-2017 re: doc. #134 received on 20-APR-2017
Affidavit of Glenn Ikeda sworn on 20-APR-2017 on behalf of Plaintiff in support of Motion Doc. No. 129 with Exhibits "1" to "7" filed on 20-APR-2017
Letter from Defendant dated 20-APR-2017 clarifying submissions made in regards to the motion to amend that was heard this morning concerning whether Millennium was the Applicant along with Janssen Inc in the underlying applications for prohibition...(scanned to Trial Judge) received on 20-APR-2017
Ottawa 20-APR-2017 BEFORE The Honourable Mr. Justice Locke Language: E Before the Court: Motion Doc. No. 119 on behalf of Defendant Result of Hearing: Matter reserved held in Court Senior Usher: Deslauriers, A. Duration per day: 20-APR-2017 from 09:54 to 11:28 Courtroom : Courtroom No. 701, 7th Floor - Thomas D'Arcy McGee Bldg. - Ottawa Court Registrar: Benoit Labelle Total Duration: 1h34min Appearances: Mr. Jonathan Giraldi, Mr. Brian Norrie (613) 695-5854 representing Plaintiff Mr. Adrian Howard, Ms. Jullian Brenner (613) 787-3557 representing Defendant Ms. Veronica Tsou (613) 786-0273 representing Patentee Comments: Dars used at hearing. Hearing Confidential. Minutes of Hearing entered in Vol. 973 page(s) 222 - 228 Abstract of Hearing placed on file
Ottawa 20-APR-2017 BEFORE Mireille Tabib, Prothonotary Language: E Before the Court: Motion Doc. No. 129 on behalf of Plaintiff Result of Hearing: Motion adjourned. Plaintiff to submit a supplementary affidavit by 4h00 today. Hearing Confidential. held in Court Senior Usher: Deslauriers, A. Duration per day: 20-APR-2017 from 09:01 to 09:36 Courtroom : Courtroom No. 701, 7th Floor - Thomas D'Arcy McGee Bldg. - Ottawa Court Registrar: Benoit Labelle Total Duration: 35min Appearances: Mr. Jonathan Giraldi, Mr. Brian Norrie (613) 695-5854 representing Plaintiff Mr. Adrian Howard, Ms. Jullian Brenner (613) 787-3557 representing Defendant Ms. Veronica Tsou (613) 786-0273 representing Patentee Comments: Dars used at hearing. Hearing Confidential. Minutes of Hearing entered in Vol. 973 page(s) 218 - 221 Abstract of Hearing placed on file
Oral directions received from the Court: Mireille Tabib, Prothonotary dated 19-APR-2017 directing that 'The Court is prepared to allow the parties' requests to remove certain portions of the motion records, but wishes to hear counsel in respect of that part of Teva's motion seeking a confidentiality order in respect of other portions of the records (or leave that these portions remain sealed). In particular, the Court is not satisfied that the evidence supports the confidentiality of any part of Tabs 12 and 17 of Janssen's record, or of Tabs 1A and 2 of Teva's responding record, and that to the extent confidentiality can be justified in respect of portions of Tabs 13, 14 and 15 of Janssen¿s record and of Tab 1K of Teva's responding record, the concerns can be adequately addressed by redactions. Counsel are asked to attend at the Court in Ottawa at 9 am on April 20, 2017 to make representations on that motion.' placed on file on 19-APR-2017 Confirmed in writing to the party(ies)
Communication to the Court from the Registry dated 19-APR-2017 re: Janssen/Millennium letter and Teva's motion record received/filed on April 19th re: show cause why materials should remain sealed in motion records filed for the motion to amend being heard April 20, 2017. (sent to CMJ)
Covering letter from Plaintiff dated 19-APR-2017 concerning Doc. Nos. 132 133 placed on file on 19-APR-2017
Solicitor's certificate of service on behalf of Jonathan Giraldi confirming service of doc. #132 upon Defendants by personal service on 19-APR-2017 confirming service doc. #132 upon Patentee Added Pursuant to s. 55(3) of the Patent Act by personal service on 19-APR-2017 filed on 19-APR-2017
Motion Record containing the following original document(s): 129 130 131 Number of copies received: 3 on behalf of Plaintiff filed on 19-APR-2017
Written Representations contained within a Motion Record on behalf of Plaintiff concerning Motion Doc. No. 129 filed on 19-APR-2017
Affidavit of Glenn Ikeda sworn on 18-APR-2017 contained within a Motion Record on behalf of Plaintiff in support of Motion Doc. No. 129 filed on 19-APR-2017
Notice of Motion contained within a Motion Record on behalf of Plaintiff in writing to be placed before the Court in Ottawa for an Order 1. Permitting the following documents to remain sealed: Tabs 12-15 of Vol. 3 from Janssen's Motion Record on its Motion to Amend; and Tabs 1A, 1B, 1K and 2 from Teva's Confidential Responding MOtion Record on Janssen's Motion to Amend. 2. Permitting Teva to refile copies of its Public and Confidential Responding Motion Record such that Tabs 1C and 1D are removed from the Confidential Responding Motion Record, such that the Public version will now contain Tabs 1E-1J. filed on 19-APR-2017
Letter from Defendants(Jenssen/Millennium) dated 19-APR-2017 on consent of Teva, proposing resolutions for its confidential information in its moving motion record further to the direction issued on April 18, 2017... received on 19-APR-2017
Oral directions received from the Court: Mireille Tabib, Prothonotary dated 18-APR-2017 directing that 'The protective order pursuant to which both parties have purported to file sealed motion records does not allow filing of materials under seal unless for the purpose of a motion for a confidentiality order. No such motion has been filed by either party. The parties have until noon on April 19, 2017 to show cause why the sealed material should not be unsealed and placed on the public record, or removed from the Court's record.' placed on file on 18-APR-2017 Confirmed in writing to the party(ies)
Covering letter from the Plaintiff (Defendant by Counterclaim) Teva Canada Limited dated 13-APR-2017 concerning the Responding Motion Record ( Confidential & Public Version) placed on file on 13-APR-2017
Solicitor's certificate of service on behalf of Jonathan Giraldi confirming service of of Teva's Confidential Responding Motion Record and Book of Authorities upon all parties by hand on 13-APR-2017 filed on 13-APR-2017
Book of Authorities consisting of 1 volume(s) on behalf of Plaintif (Defendant by Counterclaim) Teva Canada Limited received on 13-APR-2017
Pubic Version of Responding Motion Record on behalf of the Plaintiff (Defendant Teva Canada Limited) containing the Affidavit of Dawn Trach and the Written Representations in response to document #119 filed on 13-APR-2017
Sealed envelope pursuant to "Unsealed pursuant to the Order and Reasons (Tabib. P)dated May 2, 2017" on behalf of the Plaintiff (Denfendant by Counterclaim) Teva Canada Limited purporting to contain Responding Motion Record containing the following original documents(s): 124, 125 in response to document #119 Filed on 13-APR-2017
Written Written Representations contained within a Motion Record on behalf of Plaintiff (Denfendant by Counterclaim) Teva Canada Limited) concerning Motion Doc. No. 119 filed on 13-APR-2017
Affidavit of Dawn Trach sworn on 12-APR-2017 contained within a Motion Record on behalf of Plaintiff (Defendant by Counterclaim) Teva Canada Ltd. in opposition to Motion Doc. No. 119 with Exhibits "A" to "K" filed on 13-APR-2017
Covering letter from the Defendants/Plaintiffs by Counterclaim dated 07-APR-2017 concerning Docs. 122, 123 and Book of Authorities placed on file on 07-APR-2017
Solicitor's certificate of service on behalf of Jillian Brenner confirming service of the Motion Record and Book of Authorities of the Defendants/Plaintiffs by Counterclaim upon the Plaintiff/Defendant by Counterclaim by personal service on 07-APR-2017 confirming service the Motion Record and Book of Authorities of the Defendants/Plaintiffs by Counterclaim upon Patentee by Counterclaim, USA represented by Dept of Health & Human Services by courier on 07-APR-2017 filed on 07-APR-2017
Book of Authorities consisting of 1 volume(s) on behalf of the Defendants/Plaintiffs by Counterclaim received on 07-APR-2017
Motion Record containing the following original document(s): 119 120 121 Number of copies received: 3 on behalf of Defendants/Plaintiffs by Counterclaim (3 vols)-Vol.3 UNSEALED-SEE DOC. 139 filed on 07-APR-2017
Written Representations contained within a Motion Record on behalf of the Defendants/Plaintiffs by Counterclaim concerning Motion Doc. No. 119 filed on 07-APR-2017
Affidavit of Angela Malcolm sworn on 07-APR-2017 contained within a Motion Record on behalf of the Defendants/Plaintiffs by Counterclaim in support of Motion Doc. No. 119 with Exhibits 1-7 filed on 07-APR-2017
Notice of Motion contained within a Motion Record on behalf of the Defendants/Plaintiffs by Counterclaim returnable at Special Sitting in Ottawa on 20-APR-2017 to begin at 09:30 for an Order a. Granting leave to Millennium and J&J to file the Second Amended Statement of Defence and Counterclaim as attached at Schedule A to this Notice of Motion, with confidential particulars attached at Schedule B to this Notice of Motion; b. Costs of this motion, in any event of the cause; and c. Such further and other relief as this Honourable Court deems just. filed on 07-APR-2017
Ottawa 10-APR-2017 BEFORE Mireille Tabib, Prothonotary Language: E Before the Court: Case Management Conference Result of Hearing: A further CMTC will be held at 3:30p.m. on June 12, 2017. Parties can write to the Court to dispense with this CMC if the schedule does not require amendments. Counsel will provide the Court with a draft schedule reflecting what was agreed to at the TMC (Locke, J.) and CMC (Tabib, P.)held today. held in Court by way of Conference Call Senior Usher: R. Héroux Duration per day: 10-APR-2017 from 11:00 to 11:25 Courtroom : Federal Court of Appeal Courtroom - Ottawa Court Registrar: Christen Clement Total Duration: 25min Appearances: B. Norrie/J. Giraldi/D. Aitken 613-903-5109 representing Teva Cda Ltd. J. Mills/B. Moore/A. Howard 613-369-4782 representing Millennium/Janssen A. Skodyn 416-865-2882 representing Janssen K. Murphy 613-786-0273 representing Patentee(USA) Minutes of Hearing entered in Vol. 972 page(s) 419 - 423 Abstract of Hearing placed on file
Ottawa 10-APR-2017 BEFORE The Honourable Mr. Justice Locke Language: E Before the Court: Trial Management Conference Result of Hearing: The parties are to submit a draft order on consent to the Court. held in Court Senior Usher: Denis Martin Duration per day: 10-APR-2017 from 10:00 to 10:50 Courtroom : Federal Court of Appeal Courtroom - Ottawa Court Registrar: Fatiha Khayou Total Duration: 50 min Appearances: Mr. David Aitken/Mr. Bryan Norrie/Mr. Jonathan Giraldi Tel: 613.903.5109 representing Plaintiff Mr. James Mills/Ms. Beverly Moore/Mr. Adrian Howard/Andrew Skydowm Tel: 613.787.3557 representing Defendant (Millennuim) Mr. Kiernan Murphy Tel: 613.786.8681 representing (United States Government-Patentee) Janssen Comments: A draft order on consent will be provided to the Court's attention DARS and back up recording were used for this hearing Minutes of Hearing entered in Vol. 972 page(s) 400 - 402 Abstract of Hearing placed on file
Letter from Plaintiff dated 07-APR-2017 providing a proposed agenda for the TMC scheduled April 10, 2017 (scanned to the Trial Judge and the CMJ on 7-Apr-2017) received on 07-APR-2017
Order dated 04-APR-2017 rendered by Mireille Tabib, Prothonotary Matter considered with personal appearance The Court's decision is with regard to Motion Doc. No. 75 Result: granted in part Filed on 04-APR-2017 certified copies sent to parties Transmittal Letters placed on file. entered in J. & O. Book, volume 1331 page(s) 21 - 26 Interlocutory Decision
Oral directions received from the Court: The Honourable Mr. Justice Locke dated 04-APR-2017 directing that "The defendants' motion to amend will be heard in Ottawa on April 20, 2017 beginning at 9:30am for two hours. The defendants' motion record shall be served and filed by a date to be agreed by the parties. The responding motion record shall be served and filed no later than noon on April 13, 2017." placed on file on 04-APR-2017 Confirmed in writing to the party(ies)
Letter from Defendants (Janssen/Millennium) dated 31-MAR-2017 on consent of Teva, asking that this letter be brought to the attention of the CMJ and the Trial Judge. Defendants advise they will be bringing a motion to Amend its Statement of Defence and Counterclaim, and request that it be heard by Mr. Justice Locke for 2 hours on the following proposed mutual dates: April 18, 20, 21, 24-28. Parties shall prepare a schedule for filing motion materials once they have the Court's availability...(scanned to CMJ/Trial Judge) received on 31-MAR-2017
Acknowledgment of Receipt received from all parties with respect to Orders doc. 115, 116 and 177 placed on file on 31-MAR-2017
Order dated 30-MAR-2017 rendered by Mireille Tabib, Prothonotary Matter considered without personal appearance The Court's decision is with regard to Motion Doc. No. 85 Result: granted in part Filed on 30-MAR-2017 copies sent to parties entered in J. & O. Book, volume 1330 page(s) 323 - 329 Interlocutory Decision
Order dated 30-MAR-2017 rendered by Mireille Tabib, Prothonotary Matter considered with personal appearance The Court's decision is with regard to Motion Doc. No. 80 Result: granted in part Filed on 30-MAR-2017 copies sent to parties entered in J. & O. Book, volume 1330 page(s) 315 - 322 Interlocutory Decision
Order dated 30-MAR-2017 rendered by Mireille Tabib, Prothonotary Matter considered with personal appearance The Court's decision is with regard to Motion Doc. No. 70 Result: granted in part Filed on 30-MAR-2017 copies sent to parties entered in J. & O. Book, volume 1330 page(s) 309 - 314 Interlocutory Decision
Covering letter from Plaintiff dated 16-MAR-2017 concerning the Draft Order (ID 233) placed on file on 16-MAR-2017
Draft Order concerning the motion to compel received on 16-MAR-2017
Letter from Defendants and Plaintiffs by Counterclaim dated 16-MAR-2017 advising that the parties disagree as to the wording for one set of items and therefore providing two draft orders re: motions to compel heard February 28 and March 2, one for each party's position received on 16-MAR-2017
Letter from Patentee, USA, represented by the Secretary, Department of Health to the Court cc to the parties dated 16-MAR-2017 providing a draft Order for USA as per Madam Prothonotary Tabib's instructions after hearing the parties' motions to compel answers to questions refused during examination. received on 17-MAR-2017
Request for a copy of the DARS recording of the confidential hearing held on 02-Mar-2017 on behalf of Gowling WLG (Patentee) received on 15-MAR-2017
Request on behalf of Gowling WLG (Patentee) for a Dars Audio Recording of the hearing held on February 28, 2017. (Confidential) placed on file on 08-MAR-2017
Ottawa 28-FEB-2017 BEFORE Mireille Tabib, Prothonotary Language: E Before the Court: Motion Doc. No. 70 on behalf of Janssen/Millennium Result of Hearing: Matter partially granted Before the Court: Motion Doc. No. 75 on behalf of Teva (re: USA) Result of Hearing: Matter partially granted Before the Court: Motion Doc. No. 80 on behalf of Teva(re: Janssen) Result of Hearing: Matter partially granted Before the Court: Motion Doc. No. 85 on behalf of Teva (re: Millennium) Result of Hearing: Matter partially granted held in Court Senior Usher: Michel Deslauriers Duration per day: 28-FEB-2017 from 09:55 to 04:40 Courtroom : Courtroom No. 701, 7th Floor - Thomas D'Arcy McGee Bldg. - Ottawa Court Registrar: Christen Clement 02-MAR-2017 from 09:30 to 04:40 Courtroom : Courtroom No. 701, 7th Floor - Thomas D'Arcy McGee Bldg. - Ottawa Court Registrar: Christen Clement Total Duration: 2d Appearances: Bryan Norrie/Jonathan Giraldi 613-903-5109 representing Teva Canada Ltd. Adrian Howard/Beverley Moore 613-787-3557 representing Millennium/Janssen Christopher Van Barr/Veronica Tsou 613-786-8681 representing United States Government-Patentee Comments: DARS(Z009193) was used to record this CONFIDENTIAL hearing. The Court directed that a recording of this hearing can be made by counsel of record without leave, and otherwise will require permission from the Court. The parties will be notified of any such request and be given an opportunity to to make any motion for confidentiality they feel appropriate. The Court take costs submissions on the Teva-US Govenment motion(Doc.75)under reserve. Counsel for the remaining 3 motions (Docs. 70,80,85) are to provide submissions on costs within 2 weeks, along with draft orders. Minutes of Hearing entered in Vol. 970 page(s) 362 - 398 Abstract of Hearing placed on file
Covering letter from Plaintiff dated 27-FEB-2017 concerning Doc. Nos. 113 114 placed on file on 27-FEB-2017
Solicitor's certificate of service on behalf of Jonathan Giraldi confirming service of ID 225 upon Defendants (Plaintiffs by Counterclaim) by courier on 27-FEB-2017 filed on 27-FEB-2017
Sealed Envelope contanining Transcript of cross-examination of Mark Vickers as per ID 224 filed on 27-FEB-2017
Oral directions received from the Court: Mireille Tabib, Prothonotary dated 27-FEB-2017 directing that Re: Teva's letter seeking leave to file the transcript of cross-examination on Millennium's supporting affidavit by Monday, February 27 "Accept for filing" placed on file on 27-FEB-2017 Confirmed in writing to the party(ies)
Letter from Plaintiff dated 24-FEB-2017 with consent of all parties, informing the Court that with regard to the motions to compel answers Millenium included an Affidavit in support of its responding motion record when served on February 23 and Millenium and Teva have agreed that cross-examination on that affidavit may take place the morning of February 27, 2017. Parties have agreed to file the transcript with the Court by the end of the day on February 27, 2017, if acceptable to the Court. There is also agreement to the schedule of motions and list the proposed scheduling and also outline the questions that ar no longer being pursued and will not be argued at the hearing. Scanned to CMT-Ottawa. received on 24-FEB-2017
Covering letter from the United States of America dated 23-FEB-2017 concerning Motion in Response and Book of Authorities placed on file on 23-FEB-2017
Solicitor's certificate of service on behalf of Veronica Tsou confirming service of Motion Record in Response and Book of Authorities upon Teva Canada Limited by email, on consent on 23-FEB-2017 confirming service the Motion Record in Response of the Patentee upon the Defendants and the Plaintiffs by Counterclaim by email, on consent on 23-FEB-2017 confirming service The Motion record in Response and Book of Authorities upon the Defendants and Plaintiffs by Counterclaim by email, on consent on 23-FEB-2017 filed on 23-FEB-2017
Book of Authorities consisting of 1 volume(s) on behalf of The United States of America received on 23-FEB-2017 Sent directly to Presiding Judge
CONFIDENTIAL Motion Record in Response to Motion Record doc.75 on behalf of the United States of America filed on 23-FEB-2017
Motion Record in response to Motion Doc. No. 75 containing the following original document(s): 106 107 108 109 Number of copies received: 3 on behalf of The United States of America (Public Version of the Motion Record ) filed on 23-FEB-2017
Written Representations contained within a Motion Record on behalf of The United States of America concerning Motions, Doc. Nos 75 filed on 23-FEB-2017
Affidavit of Gary Hausken sworn on 23-FEB-2017 contained within a Motion Record on behalf of The United States of America in opposition to Motion Doc. No. 75 with Exhibits A-B filed on 23-FEB-2017
Affidavit of Paul F. Rothstein sworn on 23-FEB-2017 contained within a Motion Record on behalf of The United States of America in opposition to Motion Doc. No. 75 with Exhibits A-E filed on 23-FEB-2017
Affidavit of Susan Burkhardt sworn on 23-FEB-2017 contained within a Motion Record on behalf of The United States of America's in opposition to Motion Doc. No. 75 with Exhibits A-E filed on 23-FEB-2017
Covering letter from Teva Canada Limited dated 23-FEB-2017 concerning Motion Record in Response and Book of Authorities placed on file on 23-FEB-2017
Solicitor's certificate of service on behalf of Jonathan Giraldi confirming service of Responding Motion Record and Confidential Record, Book of Authorities upon the Defendants (Plaintiffs by Counterclaim) by personal service on 23-FEB-2017 confirming service the Motion Record, Confidential Motion Record and Book of Authorities upon the Patentee by personal service on 23-FEB-2017 filed on 23-FEB-2017
Book of Authorities consisting of 1 volume(s) on behalf of Teva Canada Limited received on 23-FEB-2017 Sent directly to Presiding Judge
CONFIDENTIAL Responding Motion Record to document 70 on behalf of Teva Canada Limited filed on 23-FEB-2017
Motion Record in response to Motion Doc. No. 70 containing the following original document(s): 101 102 Number of copies received: 3 on behalf of Teva Canada Limited (Public Version of the Motion Record in Response) filed on 23-FEB-2017
Written Representations contained within a Motion Record on behalf of Teva Canada Limited concerning Motion Doc. No. 70 filed on 23-FEB-2017
Affidavit of Dawn Trach sworn on 23-FEB-2017 contained within a Motion Record on behalf of Teva Canada Limited in opposition to Motion Doc. No. 70 with Exhibits A-L filed on 23-FEB-2017
Covering letter from Defenants and Plaintiffs by Counterclaim, Jassen Inc.,et al dated 23-FEB-2017 concerning Responding Motion Record and Book of Authorities placed on file on 23-FEB-2017
Solicitor's certificate of service on behalf of Adrian Howard confirming service of Responding Motion record and Book of Authorities upon Teva Canada Limited by personal service on 23-FEB-2017 confirming service Responding Motion Record and Book of Authorities upon the Patentee by courier on 23-FEB-2017 filed on 23-FEB-2017
Book of Authorities consisting of 1 volume(s) on behalf of Plaintiffs by counterclaim, Millennium Pharmaceuticals, Inc. et al received on 23-FEB-2017 Sent directly to Presiding Judge
CONFIDENTIAL Motion Record in Response to document 80 (Volume 2 of 2) on behalf of Janssen Inc., Et al filed on 23-FEB-2017
Motion Record in response to Motion Doc. No. 80 containing the following original document(s): 96 97 Number of copies received: 3 on behalf of Janssen Inc. Et al (Volume 1 of 2) filed on 23-FEB-2017
Written Representations contained within a Motion Record on behalf of Janssen Inc. concerning Motion Doc. No. 80 filed on 23-FEB-2017
Affidavit of Angela Malcolm sworn on 23-FEB-2017 contained within a Motion Record on behalf of Janssen Inc., Et al. in opposition to Motion Doc. No. 80 with Exhibits 1-6 filed on 23-FEB-2017
CONFIENTIAL Motion in Response to document 85 (Volume 2 of 2) On behalf of Millennium Pharmaceuticals, Inc. filed on 23-FEB-2017
Motion Record in response to Motion Doc. No. 85 containing the following original document(s): 92 93 Number of copies received: 3 on behalf of Mellennium Pharmaceuticals, Inc. (Volume 1 of 2) filed on 23-FEB-2017
Written Representations contained within a Motion Record on behalf of Millennium Pharmaceuticals, Inc. concerning Motion Doc. No. 85 filed on 23-FEB-2017
Affidavit of Angela Malcolm sworn on 23-FEB-2017 contained within a Motion Record on behalf of Millennium Pharmaceuticals, Inc. in opposition to Motion Doc. No. 85 with Exhibits 1-7 filed on 23-FEB-2017
Acknowledgment of Receipt received from all parties by email with respect to Doc. 91 placed on file on 16-FEB-2017
Order dated 16-FEB-2017 rendered by Mireille Tabib, Prothonotary Matter considered with personal appearance The Court's decision is with regard to Case Management Conference Result: 1. The hearing of the motion to compel from the second round of discovery is rescheduled from June 29, 2017 to July 11, 2017. 2. The parties may, on consent and advice to the Court, modify the schedule set out in paragraphs 9, 10, 12, 13 and 14 of the Order of November 10, 2016 provided that: the last date of filing motion records not be later than July 5, 2017, and the schedule for paragraphs 12 to 14 not be delayed by more than two weeks. 3. A case management conference will be held, in person, in Ottawa at 11:00 a.m. on April 10, 2017, or immediately after the Trial Management Conference. Filed on 16-FEB-2017 certified copies sent to parties Transmittal Letters placed on file. entered in J. & O. Book, volume 1326 page(s) 443 - 444 Interlocutory Decision
Ottawa 16-FEB-2017 BEFORE Mireille Tabib, Prothonotary Language: E Before the Court: Case Management Conference to discuss the Defendant's letter dated February 14, 2017 and the hearing date for motions to compel on June 29, 2017. Result of Hearing: Motions to compel(2nd round) are re-scheduled from June 29, 2017 to July 11, 2017 in Ottawa at 9:30a.m. for 1 day. A CMC will be held in person on April 10, 2017 at 11:00a.m. after the TMC being heard in person with the Trial Judge at 10:00a.m. Parties will decide what order they want motions heard on February 28, 2017 and March 2, 2017. A CMC will no longer be heard after the motions to compel on March 2, 2017. held in chambers by way of Conference Call Duration per day: 16-FEB-2017 from 10:00 to 10:40 Courtroom : Judge's Chambers - Ottawa Court Registrar: Christen Clement Total Duration: 40min Appearances: B. Norrie/J. Geraldi 613-903-5107 representing Plaintiff A. Howard/B. Moore 613-369-4784 representing Defendant(Millennium/Janssen) M. Baird 416-865-2948 representing Defendant(Janssen) Kiernan Murphy 613-786-0273 representing USA-Patentee Comments: An Order will issue Minutes of Hearing entered in Vol. 969 page(s) 37 - 41 Abstract of Hearing placed on file
Oral directions received from the Court: Mireille Tabib, Prothonotary dated 14-FEB-2017 directing that "A case management telephone conference will be held at 10:00a.m. on February 16, 2017." placed on file on 14-FEB-2017 Confirmed in writing to the party(ies)
Letter from Plaintiff (Teva) dated 14-FEB-2017 in response to the Defendant's letter dated today. The Defendant's request is unwarranted and unprecedented. We do not see any need for a case management conference, but we are generally available this week, except Thursday between 1-2p.m. (scanned to CMJ) received on 14-FEB-2017
Letter from Defendants (Janssen/Millennium et al) dated 14-FEB-2017 regarding Teva's motions to compel served on them on February 9....'Teva is seeking to force Millennium and Janssen to waste time responding to an excessive number of questions in their responding motion materials...We thus request the Court either order Teva to withdraw and serve again its motion records by the end of this week, limited to a reasonable number of questions, or, in the alternative, convene a case management conference to discuss same..." (scanned to CMJ) received on 14-FEB-2017
Covering letter from Plaintiff dated 09-FEB-2017 concerning Doc. Nos. 79 84 89 placed on file on 09-FEB-2017
Solicitor's certificate of service on behalf of Jonathan Giraldi confirming service of Doc. 79, 84, 89 and Book of Authorities upon the Defendants and Patentee by personal service on 09-FEB-2017 filed on 09-FEB-2017
Book of Authorities consisting of 2 volume(s) on behalf of Plaintiff received on 09-FEB-2017
Motion Record containing the following original document(s): 85 86 87 88 Number of copies received: 3 on behalf of the Plaintiff (Partially Confidential) filed on 09-FEB-2017
Sealed envelope pursuant to the Order of this Court dated May 17, 2016. on behalf of Plaintiff purporting to contain Confidential Version of Written Representations Filed on 09-FEB-2017
Written Representations contained within a Motion Record on behalf of the Plaintiff (Public Redacted Version) concerning Motion Doc. No. 85 filed on 09-FEB-2017
Affidavit of Dawn Trach (Partially Confidential) sworn on 07-FEB-2017 contained within a Motion Record on behalf of Plaintiff in support of Motion Doc. No. 85 with Exhibits A-AAA filed on 09-FEB-2017
Notice of Motion contained within a Motion Record on behalf of Plaintiff returnable at Special Sitting in Ottawa on 28-FEB-2017 to begin at 09:30 for an Order to compel discovery answers from Millennium filed on 09-FEB-2017
Motion Record containing the following original document(s): 80 81 82 83 Number of copies received: 3 on behalf of Plaintiff (Partially Confidential) filed on 09-FEB-2017
Sealed envelope pursuant to order of this Court dated May 17, 2017. on behalf of Plaintiff purporting to contain Confidential Version of Written Representations Filed on 09-FEB-2017
Written Representations (Public Redacted Version) contained within a Motion Record on behalf of Plaintiff concerning Motion Doc. No. 80 filed on 09-FEB-2017
Affidavit of Drawn Trach (Partially Confidential) sworn on 07-FEB-2017 contained within a Motion Record on behalf of Plaintiff in support of Motion Doc. No. 80 with Exhibits A-UU filed on 09-FEB-2017
Notice of Motion contained within a Motion Record on behalf of Plaintiff returnable at Special Sitting in Ottawa on 28-FEB-2017 to begin at 09:30 for an Order to compel discovery answers from Janssen. filed on 09-FEB-2017
Motion Record containing the following original document(s): 75 76 77 78 Number of copies received: 3 on behalf of the Plaintiff (Partially Confidential) filed on 09-FEB-2017
Sealed envelope pursuant to Order of this Court dated May 17, 2016. on behalf of Plaintiff purporting to contain confidential version of the memorandum of fact and law. Filed on 09-FEB-2017
Memorandum of Fact and Law (Public Redacted version) contained within a Motion Record on behalf of Plaintiff filed on 09-FEB-2017
Affidavit of Dawn Trach (Partially Confidential) sworn on 07-FEB-2017 contained within a Motion Record on behalf of Plaintiff in support of Motion Doc. No. 75 with Exhibits A-Y filed on 09-FEB-2017
Notice of Motion contained within a Motion Record on behalf of Plaintiff returnable at Special Sitting in Ottawa on 28-FEB-2017 to begin at 09:30 for an Order to compel discovery answers from the United States Government. filed on 09-FEB-2017
Covering letter from Defendant dated 09-FEB-2017 concerning Doc. No. 73 placed on file on 09-FEB-2017
Solicitor's certificate of service on behalf of Adrian Howard confirming service of Doc. 73 and Book of Authorities upon Plaintiff by personal service on 09-FEB-2017 confirming service Doc. 73 and Book of Authorities upon Patentee by courrier on 09-FEB-2017 filed on 09-FEB-2017
Book of Authorities consisting of 1 volume(s) on behalf of Defendant received on 09-FEB-2017
Motion Record containing the following original document(s): 70 71 72 Number of copies received: 3 on behalf of the Defendants (Volume 3 Confidential) filed on 09-FEB-2017
Written Representations contained within a Motion Record on behalf of Defendant concerning Motion Doc. No. 70 filed on 09-FEB-2017
Affidavit of Angela Malcolm (Partially Confidential) sworn on 09-FEB-2017 contained within a Motion Record on behalf of Defendant in support of Motion Doc. No. 70 with Exhibits 1-16 filed on 09-FEB-2017
Notice of Motion contained within a Motion Record on behalf of Defendant returnable at Special Sitting in Ottawa on 28-FEB-2017 to begin at 09:30 for an Order to compel answers to questions refused during first round of discovery. filed on 09-FEB-2017
Oral directions received from the Court: The Honourable Mr. Justice Locke dated 06-FEB-2017 directing that "A trial management conference will be held in Ottawa (in person) commencing at 10:00a.m. on April 10, 2017, for a duration of 1 hour." placed on file on 06-FEB-2017 Confirmed in writing to the party(ies)
Order dated 03-FEB-2017 rendered by Mireille Tabib, Prothonotary Matter considered without personal appearance The Court's decision is with regard to Letter from Defendants dated 30-JAN-2017 Result: 1. Where, in support of a motion to compel furhter or better answers to undertakings given on discovery, or to rule on objections made on discoveries, the parties wish to file exhibits, documentary productions or transcripts designated as Confidential Information or Confidential- Financial Information pursuant to the Protective Order issued in this matter, and that the notices of motion and written representations do not disclose the subject matter of said Confidential Information or Confidential Financial Information, the exhibits, documentary productions and transcripts may be segregated from the other motion materials and be filed in sealed envelopes, and the material shall be treated as confidential, in accordance with Rule 152. The Court, however, shall retain its discretion as to the terms and conditions of use of this Confidential Information or Confidential-Financial Information and the maintenance of the confidentiality thereof during the hearing of the motion(s) and in resulting opportunity to speak to and provide evidence supporting the need to maintain confidentiality. 2. For the purpose of paragraph 1, where it is not reasonably practical to segregate Confidential information, the parties may file an entire document or volume thereof in a sealed envelope, provided that the public version of the document or volune, from which the Confidential Information or Confidential- Financial Information has been redacted or removed, is also on the public record Filed on 03-FEB-2017 entered in J. & O. Book, volume 1325 page(s) 289 - 292 Interlocutory Decision
Communication to the Court from the Registry dated 01-FEB-2017 re: Defendant's letter dated Jan. 30 jointly seeking an amended Protective Order and Plaintiff's letter dated Jan. 31 advising of TMC dates with the Trial Judge
Letter from Plaintiff dated 31-JAN-2017 on behalf of all parties advising the Court of their availability for a TMC pursuant to the Court's Order dated November 10, 2016...(scanned to Trial Judge and CMJ) received on 31-JAN-2017
Letter from Defendant dated 30-JAN-2017 on consent of the Plaintiff, seeking to amend the current Protective Order to include a provision that allows for the filing of confidential information on their motions to compel...(proposed amendments enclosed with a draft Amended Prottective Order) received on 30-JAN-2017
Acknowledgment of Receipt received from 4 counsel for the parties by fax on 21-NOV-2016 with respect to Order doc. 68 of the Chief Justice, signed by the Hearings Coordinator, dated 18-NOV-2016 and received in the Ottawa Registry and filed on 21-NOV-2016. placed on file on 21-NOV-2016
Order (time and place) dated 18-NOV-2016 rendered by Chief Justice Crampton and signed by Judicial Administrator fixing Trial of the matter to be heard at Special Sitting in Ottawa on 15-JAN-2018 to begin at 09:30 duration: 35d language: E Filed on 21-NOV-2016 cc's sent to 4 counsel for the parties by fax on 21-NOV-2016 entered in J. & O. Book, volume 1319 page(s) 198 - 199 Transmittal letters placed on file
Acknowledgment of Receipt received from all parties by email with respect to Doc.67 placed on file on 14-NOV-2016
Order dated 10-NOV-2016 rendered by Mireille Tabib, Prothonotary Matter considered with personal appearance The Court's decision is with regard to Case Management Conference Result: 1. On or before January 31, 2016, the parties shall provide their availability to the Court and Mr. Justice Locke for a trial management conference in March or April 2017. 2. Motion records for motions to compel answers to questions refused during first round of discovery shall be served and filed on or before February 9, 2017. 3. Responding motion records in respect of motions to compel answers to questions refused during first round of discovery shall be served and filed on or before February 23, 2017. 4. Motions to compel answers to questions refused during first round of discoveries shall be heard at a Special Sitting in Ottawa on February 28 and March 2, 2017.5. A case management conference will be held on March 2, 2017 following the hearing of the motions to compel answers, or in any event if the motions to compel answers does not need a second day. The case management conference will address any issue that has arisen and to discuss deadlines for testing.6. Questions ordered to be answered at the hearing on February 28 and March 2, 2017, or otherwise agreed to be answered, shall be provided on or before April 2, 2017. 7. The second round of examinations for discovery shall be completed by May 19, 2017.8. Answers to undertakings given during the second round of examinations for discovery shall be provided by June 9, 2017. 9. Motion records for motions to compel answers to questions refused during second round of discovery shall be served and filed on or before June 19, 2017. 10. Responding motion records in respect of motions to compel answers refused during first round of discovery shall be served and filed on or before June 26, 2017. 11. Motions to compel answers to questions refused during second round of discoveries shall be heard at a Special Sitting in Ottawa on June 29, 2017. 12. Questions ordered to be answered at the hearing on June 29, 2017, or otherwise agreed to be answered, shall be provided on or before July 28, 2017. 13. Teva Canada Ltd. shall serve its expert reports in respect of its section 8 damages and patent invalidity on or before September 1, 2017. 14. The Defendants, Plaintiffs by Counterclaim, and Patentee shall serve their expert reports, if any, in respect of patent infringement and infringement damages on or before September 1, 2017. Filed on 10-NOV-2016 certified copies sent to parties Transmittal Letters placed on file. entered in J. & O. Book, volume 1318 page(s) 303 - 305 Interlocutory Decision
Communication to the Court from the Registry dated 10-NOV-2016 re: Draft scheduling order received today
Draft Scheduling Order concerning the next steps to be taken consented to by all parties received on 10-NOV-2016
Ottawa 07-NOV-2016 BEFORE Mireille Tabib, Prothonotary Language: E Before the Court: Continuation of the Case Management Conference to set down dates and deadlines proposed at the CMC heard on October 24th Result of Hearing: Counsel will submit a joint proposed draft order held in chambers by way of Conference Call Duration per day: 07-NOV-2016 from 10:05 to 10:40 Courtroom : Judge's Chambers - Ottawa Court Registrar: Christen Clement Total Duration: 35 min Appearances: B. Norrie/J. Giraldi 613-903-5107 representing Plaintiff A. Howard/B. Moore 613-369-4784 representing Defendants(Janssen/Millennium) M. Ethier 416-865-2979 representing Defendant(Janssen) K. Murphy 613-786-0273 representing USA-Patentee Minutes of Hearing entered in Vol. 961 page(s) 218 - 223 Abstract of Hearing placed on file
Ottawa 24-OCT-2016 BEFORE Mireille Tabib, Prothonotary Language: E Before the Court: Case Management Conference to discuss the progress of the litigation, trial dates and discovery issues. Result of Hearing: See 'COMMENTS' below held in chambers by way of Conference Call Duration per day: 24-OCT-2016 from 10:00 to 10:35 Courtroom : Judge's Chambers - Ottawa Court Registrar: Christen Clement Total Duration: 35min Appearances: Bryan Norrie/Jonathan Giraldi 613-903-5107 representing Plaintiff Adrian Howard 613-787-3557 representing Defendants(Millennium/Janssen) Marguerite Ethier 416-865-2979 representing Defendant(Janssen) Kiernan Murphy 613-786-0273 representing USA-Patentee Comments: Deadlines were agreed upon to provide answers to undertakings(Jan.16/2017), briefing of motions to compel(moving records Feb.24/2017; responding records Mar.14/2017) with a hearing tentatively agreed upon for March 21 and 23 in Ottawa; questions ordered to be answered 30 days form Order. Parties are to discuss whether or not testing will be required and the amount of experts required and timing of delivery of experts. Trial dates were offered to parties from January 15, 2018 to March 14, 2018 for 35 days, sitting 4 days a week. Parties are asked to review all of the above with their clients and reconvene for a further case management telephone conference on November 7, 2016 at 10:00a.m. The deadlines above will be held until the next CMC. Minutes of Hearing entered in Vol. 960 page(s) 160 - 165 Abstract of Hearing placed on file
Certified French language Translation of ORDER AND REASONS rendered on 15-MAR-2016 by The Honourable Mr. Justice Diner filed on 23-AUG-2016 pursuant to s. 20 of the Official Languages Act. Copy of Translation of Reasons for ORDER AND REASONS entered in J. & O. Book, volume 1310 page(s) 74 - 81
Oral directions received from the Court: Mireille Tabib, Prothonotary dated 27-JUL-2016 directing that a case management telephone conference will be held at 10:00 a.m. on October 24, 2016 for the parties to update the Court as to the progress of the litigation, to discuss trial dates and to address any discovery issue the parties may raise placed on file on 27-JUL-2016 Confirmed in writing to the party(ies)
Ottawa 27-JUL-2016 BEFORE Mireille Tabib, Prothonotary Language: E Before the Court: Case Management Conference for the parties to update the Court as to the progress of the litigation discuss trial dates and to address any discovery issue the parties may raise Result of Hearing: A case management telephone conference will be held on October 24, 2016 at 10:00 held in chambers by way of Conference Call Duration per day: 27-JUL-2016 from 01:30 to 02:00 Courtroom : Judge's Chambers - Ottawa Court Registrar: Julie Dulac Total Duration: 30min Appearances: Bryan Norrie and Jonathan Giraldi 613-903-5107 representing Plaintiff Beverley Moore and Adrian Howard 613-369-4784 representing Defendant Millenium Pharmaceutical Jamie Holtom 416-865-2946 representing Defendant Janssen Kiernan Murphy 613-786-0273 representing USA Patentee Minutes of Hearing entered in Vol. 955 page(s) 266 - 268 Abstract of Hearing placed on file
Communication to the Court from the Registry dated 26-JUL-2016 re: in preparation for the CMTC on 27-Jul-2016
Solicitor's certificate of service on behalf of Kiernan A. Murphy confirming service of doc. #64 upon the Plaintiff and Defendant by Counterclaim by email on 16-JUN-2016 confirming service doc. #64 upon Defendants and the Plaintiffs by Counterclaim by email on 16-JUN-2016 filed on 16-JUN-2016
Amended Reply to Defence to Counterclaim filed on 16-JUN-2016
Covering letter from defendants and plaintiffs by counterclaim dated 16-JUN-2016 concerning Doc. Nos. 62 63 placed on file on 16-JUN-2016
Solicitor's certificate of service on behalf of Beverley Moore confirming service of Amended Reply to Defence to Counterclaim upon all parties by email on 16-JUN-2016 filed on 16-JUN-2016
Amended Reply to Defence to Counterclaim filed on 16-JUN-2016
Ottawa 16-JUN-2016 BEFORE Mireille Tabib, Prothonotary Language: E Before the Court: Case Management Conference Result of Hearing: An oral direction will issue; a further CMTC will be held July 27, 2016 held in chambers by way of Conference Call Duration per day: 16-JUN-2016 from 01:30 to 01:40 Courtroom : Judge's Chambers - Ottawa Court Registrar: Christen Clement Total Duration: 10min Appearances: Bryan Norrie/Jonathan Giraldi 613-903-5107 representing Plaintiff Beverley Moore/Adrian Howard 613-369-4784 representing Defendant Kiernan Murphy 613-786-0273 representing USA-Patentee Minutes of Hearing entered in Vol. 953 page(s) 296 - 298 Abstract of Hearing placed on file
Oral directions received from the Court: Mireille Tabib, Prothonotary dated 16-JUN-2016 directing that 'A case management telephone conference will be held at 1:30p.m. on July 27, 2016 for the parties to update the Court as to the progress of the litigation, to discuss early trial dates and to address any discovery issue the parties may raise.' placed on file on 16-JUN-2016 Confirmed in writing to the party(ies)
Covering letter from Plaintiff dated 06-JUN-2016 concerning document id 135, 136, 137, 138, 139 placed on file on 06-JUN-2016
Solicitor's certificate of service on behalf of Bryan Norrie confirming service of document 60 upon Defendant by e-mail on 06-JUN-2016 confirming service document 60 upon Patentee by e-mail on 06-JUN-2016 filed on 06-JUN-2016
Copy of a Letter from Plaintiff to counsel for the Defendants and Patentee dated 06-JUN-2016 enclosing documents received on 06-JUN-2016
Amended Reply and Defence to Counterclaim on behalf of Plaintiff Filed on 06-JUN-2016
Copy of E-mail advising that counsel for Defendants and Patentee consent to an extension and advising Plaintiff may sign draft consent on their behalf. received on 06-JUN-2016
Consent on behalf of solicitors for Teva Canada Limited, Solicitors for Defendants and Plaintiff by Counterclaim and Solicitors for the Patentee Added per s. 55(3) to to a 3 day extnesion of time for filing the Amended Reply and Defence to Counterclaim filed on 06-JUN-2016
Acknowledgment of Receipt received from all parties by email with respect to Doc. 58 placed on file on 18-MAY-2016
PROTECTIVE ORDER dated 17-MAY-2016 rendered by Mireille Tabib, Prothonotary Matter considered without personal appearance The Court's decision is with regard to Letter from Defendant dated 16-MAY-2016 re: Draft Protective Order to be issued, on consent of all parties Result: granted Filed on 18-MAY-2016 certified copies sent to parties Transmittal Letters placed on file. entered in J. & O. Book, volume 1301 page(s) 111 - 125 Interlocutory Decision
Letter from Defendant dated 16-MAY-2016 '...further to the order dated April 25, 2016, please find enclosed a draft Protective Order along with signed consent from the parties...' (scanned to CMJ) received on 16-MAY-2016
Ottawa 11-MAY-2016 BEFORE The Honourable Mr. Justice Diner Language: E Before the Court: Meeting Result of Hearing: Counsel for the Defendant agrees to costs in the amount of $2,500 held by way of Conference Call Duration per day: 11-MAY-2016 from 10:00 to 10:15 Courtroom : Judge's Chambers - Ottawa Court Registrar: Victoria Gawn Total Duration: 15min Appearances: Mr. Jonathan Giraldi and Mr. Jeffery Warnock 613-237-5160 representing Plaintiff Mr. Jamie Mills 613-903-5109 representing Defendant Minutes of Hearing entered in Vol. 951 page(s) 247 - 249 Abstract of Hearing placed on file
Oral directions received from the Court: The Honourable Mr. Justice Diner dated 10-MAY-2016 directing that "A meeting by way of teleconference will be held on Wednesday, May 11, 2016." placed on file on 10-MAY-2016
Letter from Defendant dated 06-MAY-2016 re: In response to Teva's letter dated May 4, 2016. (Scanned to Diner, J.) received on 06-MAY-2016
Covering letter from Defendants dated 04-MAY-2016 concerning Doc. Nos. 55 56 57 placed on file on 04-MAY-2016
Solicitor's certificate of service on behalf of Beverley Moore with consent to extend the time for filing confirming service of doc. #56 upon Plaintiff by personal service on 04-MAY-2016 confirming service doc. #56 upon Patentee by Counterclaim by courier on 04-MAY-2016 filed on 04-MAY-2016
Amended Defence and Counterclaim with consent of all parties filed on 04-MAY-2016
Consent on behalf of all parties to the filing of the attached Amended Statement of Defence and Counterclaim filed on 04-MAY-2016
Letter from Plaintiff dated 04-MAY-2016 re: We write in respect of Teva's costs... (Scanned to Diner, J.) received on 04-MAY-2016
Communication to the Court from the Registry dated 27-APR-2016 re: Sent to JA's office re: Paragraph 4 of Order dated April 25, 2016 (Ja to advise parties of earliest trial dates available starting Jan. 2018 for 7 week Trial in Ottawa)
Acknowledgment of Receipt received from all parties by email with respect to doc.54 placed on file on 26-APR-2016
Order dated 25-APR-2016 rendered by Mireille Tabib, Prothonotary Matter considered with personal appearance The Court's decision is with regard to Case Management Conference Result: 1. The parties will aim to finalize pleadings by May 6, 2016, and agree to a protective agreement or draft protective order. 2. To the extent the parties are unable to agree, any motions to amend pleadings or for a protective order may be made returnable at the Ottawa General Sittings of May 18, 2016, following the timelines set out in the Rules. 3. Documents from the Affidavits of Documents shall be exchanged within a week of a protective agreement or protective order being in place. 4. The Judicial Administrator will advise the parties of the earliest dates that may be available starting in January 2018 for a 7 week trial of this matter, in English, in Ottawa. 5. A case management telephone conference will be held at 1:30 p.m. on June 16, 2016 to address any issue that has arisen and to discuss fixing early trial dates. 6. The first round of examinations for discovery shall be completed by October 14, 2016. 7. Answers to undertakings given during the first round of examinations for discovery shall be provided by January 16, 2017. 8.The parties shall, within 15 days after the period for providing answers to undertakings, request a case management conference to schedule further steps in this action including any motion(s) to compel answers. Filed on 25-APR-2016 certified copies sent to parties Transmittal Letters placed on file. entered in J. & O. Book, volume 1299 page(s) 161 - 163 Interlocutory Decision
Ottawa 25-APR-2016 BEFORE Mireille Tabib, Prothonotary Language: E Before the Court: Case Management Conference Result of Hearing: SEE COMMENTS BELOW held in chambers by way of Conference Call Duration per day: 25-APR-2016 from 10:00 to 10:40 Courtroom : Judge's Chambers - Ottawa Court Registrar: Christen Clement Total Duration: 40 min Appearances: Jeffrey Warnock/Brian Norrie 613-903-5106/613-818-2315 representing Plaintiff Beverley Moore/Adrian Howard 613-369-4784 representing Defendant Kiernan Murphy 613-786-0273 representing Patentee(USA) Comments: A further CMC by teleconference is scheduled on June 16, 2016 at 1:30p.m. If parties cannot come to an agreement on the pleadings issue or the Teva- Actavis transaction, then they are to file motion records returnable at the general sittings in Ottawa on May 18 wherein the CMJ will be presiding. An agreement must be reached by May 6th, or parties are to serve and file their motion(s) in accordance with the FCR. A 'Protective Order' or 'Protective Agreement' shall be agreed upon between parties and submitted by May 6th. All parties agree to the January 2018 target date for the Trial for 7 weeks. Minutes of Hearing entered in Vol. 950 page(s) 275 - 280 Abstract of Hearing placed on file
Oral directions received from the Court: Mireille Tabib, Prothonotary dated 09-MAR-2016 directing that Re: Teva's letter dated March 7, 2016 'The hearing scheduled for March 30th may be vacated.' placed on file on 09-MAR-2016 Confirmed in writing to the party(ies)
Acknowledgment of Receipt received from parties with respect to Doc 53 placed on file on 15-MAR-2016
Order and Reasons dated 15-MAR-2016 rendered by The Honourable Mr. Justice Diner Matter considered without personal appearance The Court's decision is with regard to Motion Doc. No. 43 Result: dismissed Filed on 15-MAR-2016 certified copies sent to parties entered in J. & O. Book, volume 1296 page(s) 88 - 95 Interlocutory Decision
Letter from Plaintiff dated 07-MAR-2016 Further to the order of the Court dated March 1, 2016, we write to confirm that Teva will not oppose the Defendants' proposed amendments to its Statement of Defence and CC....As a result, parties will not need to appear before the Court on March 30, 2016 at 1:30 for a motion to amend. (scanned to CMJ) received on 07-MAR-2016
Oral directions received from the Court: Mireille Tabib, Prothonotary dated 03-MAR-2016 directing that 'Any motion to amend will be heard in Ottawa beginning at 1:30p.m. on March 30, 2016, for half day.' placed on file on 03-MAR-2016 Confirmed in writing to the party(ies)
Letter from Plaintiff dated 01-MAR-2016 confirming the parties' availability for a motion to amend the pleadings, if filed, to be heard in the afternoon of March 30, 2016. In the event the motion is not required, Teva will write to the Court by March 8, 2016 to indicate that the scheduled time can be vacated. (scanned to CMJ) received on 01-MAR-2016
Acknowledgment of Receipt received from all parties by email with respect to doc. 52 placed on file on 01-MAR-2016
Order dated 01-MAR-2016 rendered by Mireille Tabib, Prothonotary Matter considered with personal appearance The Court's decision is with regard to Case Management Conference Result: 1.All parties will, by March 3,2016, provide their dates of non-availability for the hearing of a potential motion to amend for a half-day in Ottawa during the afternoon of March 31, 2016 or the week of April 4, 2016. 2.The Plaintiff will provide its position as to whether it will consent to the Defendant¿s proposed amendments and the nature of any objections by March 7, 2016. 3. The Defendants will serve and file a motion on any motion to amend by March 11, 2016. 4. Responding records will be served and filed by March 18, 2016. 5. The parties shall exchange Affidavits of Documents by April 11, 2016. If the necessary Protective Order is in place, documents shall be exchanged at this time. If the Order is still outstanding, documents shall be exchanged within a week of the Order's issuance. 6. A case management telephone conference will be held at 10:00 a.m. on April 25, 2016 to address any issue that has arisen and to discuss fixing early trial dates. 7. The first round of examinations for discovery shall be provided by Jan. 16, 2017. 9. The parties shall, within 15 days after the period for providing answers to undertakings, request a case management conference to schedule further steps in this action including any motion(s) to compel answers. Filed on 01-MAR-2016 certified copies sent to parties Transmittal Letters placed on file. entered in J. & O. Book, volume 1294 page(s) 233 - 235 Interlocutory Decision
Ottawa 01-MAR-2016 BEFORE Mireille Tabib, Prothonotary Language: E Before the Court: Case Management Conference to discuss issues arising from counsel's letters dated February 10 and 11 and to discuss fixing an early trial date Result of Hearing: An Order will issue held in chambers by way of Conference Call Duration per day: 01-MAR-2016 from 10:00 to 10:25 Courtroom : Judge's Chambers - Ottawa Court Registrar: Christen Clement Total Duration: 25min Appearances: Bryan Norrie/Jeffrey Warnock 613-903-5107 representing Plaintiff Beverley Moore/Adrian Howard 613-369-4784 representing Defendant Kiernan Murphy 613-786-0273 representing USA-Patentee Comments: Parties are to advise the Court by March 3, 2016 of their dates of non-availability to argue the Defendant's potential motion to amend their pleadings. Dates provided by the Court to hear the motion in Ottawa are: March 30, April 4,5,6,7,8. A Draft Protective Order on consent will be submitted to the Court in the near future. An order will issue detailing the amendments to the schedule as agreed to by all parties. A CMTC will be held on April 25, 2016 at 10:00a.m. Minutes of Hearing entered in Vol. 947 page(s) 100 - 105 Abstract of Hearing placed on file
Ottawa 24-FEB-2016 BEFORE The Honourable Mr. Justice Diner Language: E Before the Court: Motion Doc. No. 43 on behalf of Defendant Result of Hearing: Matter reserved held in Court Senior Usher: Pierre Gendron Duration per day: 24-FEB-2016 from 11:00 to 12:40 Courtroom : Conference Room 1104, 11th Floor - Thomas D'Arcy McGee Bldg. - Ottawa Court Registrar: Victoria Gawn Total Duration: 1h 40min Appearances: Mr. Jonathan Giraldi and Mr. Jeffrey Warnock 613-695-5858 representing Plaintiff Mr. Jamie Mills 613-369-4782 representing Defendant Comments: DARS Z006665 Minutes of Hearing entered in Vol. 947 page(s) 22 - 25 Abstract of Hearing placed on file
Oral directions received from the Court: Mireille Tabib, Prothonotary dated 22-FEB-2016 directing that The case management teleconference scheduled for today is adjourned to March 1, 2016 at 10:00a.m. placed on file on 22-FEB-2016 Confirmed in writing to the party(ies)
Adjournment letter dated 17-FEB-2016 received on 17-FEB-2016 from Defendant confirming previously recorded adjournment by telephone call received on 17-FEB-2016 placed on file.
Correction to General Sitting concerning Motion Doc. No. 43 Hearing rescheduled from General Sitting at Ottawa on 17-FEB-2016 to General Sitting at Ottawa on 24-FEB-2016 at 09:30 duration: 1h 30min Language: E Reason for correction: Oral request for Adjournment with consent of all parties (allowed by presiding Judge) formal letter to follow
Covering letter from Plaintiff/Defendant by Counterclaim - Teva Canada Ltd. dated 15-FEB-2016 concerning Doc. Nos. 49 50 51 placed on file on 15-FEB-2016
Solicitor's certificate of service on behalf of Jeffrey Warnock with consent to extend the time for filing confirming service of Doc. # 49 and Book of Authorities upon Defendants and Patentee Added Pursuant to s. 55(3) of the Patent Act by email on 15-FEB-2016 filed on 15-FEB-2016
Consent on behalf of all parties to electronic service of material on February 15, 2016, with a hard copy to follow on the next business day. filed on 15-FEB-2016
Book of Authorities consisting of 1 volume(s) on behalf of Plaintiff/Defendant by Counterclaim - Teva Canada Ltd. received on 15-FEB-2016
Motion Record in response to Motion Doc. No. 43 containing the following original document(s): 48 Number of copies received: 3 on behalf of Plaintiff/Defendant by Counterclaim - Teva Canada Ltd. filed on 15-FEB-2016
Written Representations contained within a Motion Record on behalf of Plaintiff/Defendant by Counterclaim - Teva Canada Ltd. concerning Motion Doc. No. 43 filed on 15-FEB-2016
Oral directions received from the Court: Mireille Tabib, Prothonotary dated 11-FEB-2016 directing that The issues raised in the Defendant¿s letter, as well as the scheduling of any motion that may be required as a result of these issues being raised, may be discussed at the case conference on February 22, 2016. The Court urges counsel for the parties to meet or speak with each other directly to attempt to resolve as many issues as possible before then.¿ placed on file on 11-FEB-2016 Confirmed in writing to the party(ies)
Covering letter from Defendant dated 11-FEB-2016 concerning Doc. Nos. 46 47 placed on file on 11-FEB-2016
Solicitor's certificate of service on behalf of Jamie Mills confirming service of Motion Record Doc. No 46 and Book of Authorities upon Plaintiff and Patentee by personal service on 11-FEB-2016 filed on 11-FEB-2016
Book of Authorities in support of Motion Record Doc. No. 46 consisting of 1 volume(s) on behalf of Defendant received on 11-FEB-2016
Motion Record containing the following original document(s): 45 Number of copies received: 3 on behalf of Defendant (2 volumes filed) filed on 11-FEB-2016
Written Representations contained within a Motion Record on behalf of Defendant concerning Motion Doc. No. 43 filed on 11-FEB-2016
Letter from Plaintiff dated 11-FEB-2016 in reply to the Defendants letter dated February 10th...and now request that the case management teleconference scheduled on February 22 to discuss an early trial, instead be used to clarify issues raised in the Defendant's letter. received on 11-FEB-2016
Letter from Defendant dated 10-FEB-2016 seeking an extension of time of the February 11th deadline to serve their affidavit of documents... received on 10-FEB-2016
Solicitor's certificate of service on behalf of Jamie Mills confirming service of Notice of Motion doc.43 upon all parties by telecopier on 05-FEB-2016 filed on 05-FEB-2016
Notice of Motion on behalf of Plaintiffs by Counterclaim (Millennium and Janssen) returnable at General Sitting in Ottawa on 17-FEB-2016 to begin at 09:30 duration: 1h 30min language: E for an Order pursuant to R.51 setting aside the Order of Prothonotary Tabib dated 26-JAN- 2016; an Order pursuant to the FC's draft model bifurcation Order attached as Schedule "A" to this Notice of Motion and R.107 that the quantification issues in this action shall be determined separately from and only after the Liability Phase, if necessary, depending upon the outcome of the Liability Phase...and other relief. filed on 05-FEB-2016
Order dated 26-JAN-2016 rendered by Mireille Tabib, Prothonotary Matter considered with personal appearance The Court's decision is with regard to Motion Doc. No. 25 Result: dismissed Filed on 26-JAN-2016 certified copies sent to parties Transmittal Letters placed on file. entered in J. & O. Book, volume 1291 page(s) 130 - 134 Interlocutory Decision
Ottawa 20-JAN-2016 BEFORE Mireille Tabib, Prothonotary Language: E Before the Court: Motion Doc. No. 25 on behalf of Defendant for a bifurcation order Result of Hearing: Matter reserved held in Court Senior Usher: John Charlebois Duration per day: 20-JAN-2016 from 01:30 to 03:05 Courtroom : Conference Room 1104, 11th Floor - Thomas D'Arcy McGee Bldg. - Ottawa Court Registrar: Christen Clement Total Duration: 1h35min Appearances: Beverley Moore/Adrian Howard/Jamie Mills 613-369-47-84 representing Defendant Bryan Norrie/Jeffrey Warnock 613-903-5106 representing Plaintiff Minutes of Hearing entered in Vol. 944 page(s) 332 - 339 Abstract of Hearing placed on file
Letter from United States of America(Patentee) dated 20-JAN-2016 in respect to the defendant's motion to bifurcate, advising the Court that they take no position and their client does not intend to attend or be represented at the hearing. (scanned to CMJ) received on 20-JAN-2016
Covering letter from Plaintiff dated 15-JAN-2016 concerning Doc. Nos. 38 39 placed on file on 15-JAN-2016
Covering letter from Defendants dated 15-JAN-2016 concerning Doc. Nos. 40 41 placed on file on 15-JAN-2016
Solicitor's certificate of service on behalf of Adrian Howard confirming service of doc. #40 upon Plaintiff by personal service on 15-JAN-2016 confirming service doc. #40 upon Patentee by Counterclaim by personal service on 15-JAN-2016 filed on 15-JAN-2016
Supplementary Motion Record in response to Motion Doc. No. 25 containing the following original document(s): 39 Number of copies received: 3 on behalf of Defendants filed on 15-JAN-2016
Written Submissions (Supplemental) contained within a Motion Record on behalf of Defendants concerning Motion Doc. No. 25 filed on 15-JAN-2016
Supplementary Motion Record in response to Motion Doc. No. 25 containing the following original document(s): 37 Number of copies received: 3 on behalf of the Plaintiff (Teva Canada Limited) filed on 15-JAN-2016
Written Representations (Supplemental) contained within a Motion Record on behalf of the Plaintiff (Teva Cnaada Limited) concerning Motion Doc. No. 25 filed on 15-JAN-2016
Acknowledgment of Receipt received from all parties by email with respect to doc.36 placed on file on 13-JAN-2016
Order dated 12-JAN-2016 rendered by Mireille Tabib, Prothonotary Matter considered without personal appearance The Court's decision is with regard to Letter from Defendant dated 11-JAN-2016 re: joint request to extend time to exchanfe affidavits of documents until February 11, 2016. Result: granted Filed on 12-JAN-2016 certified copies sent to parties Transmittal Letters placed on file. entered in J. & O. Book, volume 1289 page(s) 211 - 212 Interlocutory Decision
Communication to the Court from the Registry dated 11-JAN-2016 re: Defendant's letter jointly seeking an extension to exchange affidavits of documents
Letter from Defendants(Janssen Inc/Millennium) dated 11-JAN-2016 Advising the Court that parties have agreed to move the date for exchanging affidavits of documents to February 11 to allow for a determination on the bifurcation motion...a draft order and consent regarding same is attached. received on 11-JAN-2016
Oral directions received from the Court: Mireille Tabib, Prothonotary dated 04-JAN-2016 directing that "The motion is adjourned from January 7, 2016 to January 20, 2016 beginning at 1:30p.m. Transcripts and supplemental submissions, if any, are to be served and filed no later than noon on January 15, 2016," placed on file on 04-JAN-2016 Confirmed in writing to the party(ies)
Covering letter from Plaintiff dated 31-DEC-2015 concerning Doc. Nos. 32 33 34 35 placed on file on 31-DEC-2015
Solicitor's certificate of service on behalf of Jeffrey Warnock confirming service of Doc#34 Plaintiff's responding motion record re. Bifurcation upon Defendant by email on 31-DEC-2015 filed on 31-DEC-2015
Book of Authorities consisting of 1 volume(s) on behalf of Plaintiff received on 31-DEC-2015
Motion Record in response to Motion Doc. No. 25 containing the following original document(s): 32 33 Number of copies received: 3 on behalf of Plaintiff filed on 31-DEC-2015
Written Representations contained within a Motion Record on behalf of Plaintiff concerning Motion Doc. No. 25 filed on 31-DEC-2015
Affidavit of Glenn Ikeda sworn on 30-DEC-2015 contained within a Motion Record on behalf of Plaintiff in opposition to Motion Doc. No. 25 filed on 31-DEC-2015
Communication to the Court from the Registry dated 24-DEC-2015 re: Plaintiff's letter dated 22-Dec-2015 (sent to the CMJ by e-mail)
Letter from Plaintiff dated 22-DEC-2015 requesting that the hearing of the bifurcation motion presently scheduled to be heard on January 7, 2016 be adjournedto take place between January 18 and 20, 2015 received on 22-DEC-2015
Covering letter from Defendant dated 14-DEC-2015 concerning Doc. 30 & ID:65 placed on file on 14-DEC-2015
Solicitor's certificate of service on behalf of Adrian Howard confirming service of Doc. 30 & ID:65 upon all parties by hand(TEVA) and electronically on consent(Patentee/USA) on 14-DEC-2015 filed on 14-DEC-2015
Book of Authoritires(RE: Motion #25) consisting of 1 volume(s) on behalf of Defendant received on 14-DEC-2015
Motion Record containing the following original document(s): 25 26 27 28 29 Number of copies received: 3 on behalf of Defendants(Millennium/Janssen) filed on 14-DEC-2015
Written Representations contained within a Motion Record on behalf of Defendants(Millennium/Janssen) concerning Motion Doc. No. 25 filed on 14-DEC-2015
Affidavit of Greg McEvoy sworn on 14-DEC-2015 contained within a Motion Record on behalf of Defendant in support of Motion Doc. No. 25 with Exhibits A-B filed on 14-DEC-2015
Affidavit of Neil Palmer sworn on 14-DEC-2015 contained within a Motion Record on behalf of Defendant in support of Motion Doc. No. 25 with Exhibits A-B filed on 14-DEC-2015
Affidavit of Angela Malcolm sworn on 14-DEC-2015 contained within a Motion Record on behalf of Defendant in support of Motion Doc. No. 25 with Exhibits A to G filed on 14-DEC-2015
Draft Order concerning Motion Doc. No. 25 received on 14-DEC-2015
Notice of Motion contained within a Motion Record on behalf of Defendants(Milennium/Janssen) returnable at a special sitting on January 7, 2016 at 9:30 in Ottawa(.5d) for an Order pursuant to Rule 107(bifucation) that the quantification issues in this action shall be detemined seperately from, and only after the Liability Phase, if necessary, depending upon the outcome of the Liability Phase... filed on 14-DEC-2015 Draft Order\\Judgment received.
Acknowledgment of Receipt received from all parties by email with respect to Doc.24 placed on file on 15-DEC-2015
Order dated 15-DEC-2015 rendered by Mireille Tabib, Prothonotary Matter considered without personal appearance The Court's decision is with regard to Letter from Defendant dated 11-DEC-2015 re: requesting an extension until December 14th to serve/file their motion to bifurcate, on consent of all parties Result: granted 1. The Scheduling Order dated Oct. 8, 2015 is hereby amended to provide Defedants and Plaintiffs by Counterclaim an extension of time to serve and file the motion record for the motion to bifurcate to Dec. 14, 2015. Filed on 15-DEC-2015 certified copies sent to parties Transmittal Letters placed on file. entered in J. & O. Book, volume 1286 page(s) 316 - 317 Interlocutory Decision
Memorandum to file from Toronto dated 14-DEC-2015 Defendants-Janssen is represented by both Borden Ladner Gervais LLP and Lenczner Slaght Royce Smith Griffin LLP placed on file.
Solicitor's certificate of service on behalf of Marguerite Ethier confirming service of doc 22 upon all parties by telecopier on 11-DEC-2015 filed on 14-DEC-2015
Notice of change of solicitor on behalf of Defendant-Janssen Inc. filed on 14-DEC-2015
Communication to the Court from the Registry dated 14-DEC-2015 re: Defendant's letter jointly seeking an extension of time until December 14 to serve and file the motion to bifurcate. Consent attached.
Consent on behalf of all parties to attached draft order extending the time to serve and file motion record to bifurcate filed on 11-DEC-2015
Letter from Defendants dated 11-DEC-2015 requesting an extension of time on consent to serve and file the motion record re: motion to bifurcate received on 11-DEC-2015
Covering letter from Patentee dated 30-NOV-2015 concerning Doc. Nos. 19 20 placed on file on 30-NOV-2015
Solicitor's certificate of service on behalf of Kiernan A. Murphy confirming service of Doc. 19 upon all parties by email on 30-NOV-2015 filed on 30-NOV-2015
Reply to Defence to Counterclaim on behalf of Patentee Filed on 30-NOV-2015
Covering letter from Defendants and Plaintiffs by Counterclaim, Janssen Inc. and Millenium dated 30-NOV-2015 concerning Doc. Nos. 17 18 placed on file on 30-NOV-2015
Solicitor's certificate of service on behalf of Beverley Moore confirming service of Document #17 upon all parties by electronic service on 30-NOV-2015 filed on 30-NOV-2015
Reply and Defence to Counterclaim on behalf of the Plaintiffs by counterclaim Filed on 30-NOV-2015
Acknowledgment of Receipt received from all parties by email with respect to Doc.16 placed on file on 09-OCT-2015
Order dated 08-OCT-2015 rendered by Mireille Tabib, Prothonotary Matter considered with personal appearance The Court's decision is with regard to Case Management Conference Result: 1.The Plaintiffs by counterclaim and the Patentee file their Reply to Teva's Reply and Defence to Counterclaim by November 30,2015. 2. Defendants to serve/file motion record(s) on a motion to bifurcate by 11-DEC-2015. 3. Responding records shall be served/filed by 31-DEC-2015. 4. Motion to bifurcate will be heard in Ottawa beginning at 9:30a.m. on Jan. 7, 2016 for half day. 5. Parties shall exchange affidavits of Documents by 29-JAN-2016. If the necessary Prottective Order is in place, documents shall be exchanged at this time. If the Order is still outstanding, documents shall be exchanged within a week of the Orders issuance. 6. A CMTC will be held at 10:00a.m. on 22-FEB-2016 to address any issue that has arisen and to discuss fixing early trial dates. 7. First round of examinstions for discovery completed by 29-JUL-2016. 8. Answers to underakings provided by 14-OCT-2016. 9. The parties shall, within 15 days after the period for providing answers to undertakings, request a CMTC to schedule further steps in this action including any motion(s) to compel answers. Filed on 08-OCT-2015 certified copies sent to parties Transmittal Letters placed on file. entered in J. & O. Book, volume 1279 page(s) 361 - 363 Interlocutory Decision
Ottawa 07-OCT-2015 BEFORE Mireille Tabib, Prothonotary Language: E Before the Court: Case Management Conference to discuss the proposed draft timetable Result of Hearing: An Order will be issued held in chambers by way of Conference Call Duration per day: 07-OCT-2015 from 03:30 to 04:05 Courtroom : Judge's Chambers - Ottawa Court Registrar: Christen Clement Total Duration: 35min Appearances: Bryan Norrie 613-818-xxxx representing Plaintiff Beverley Moore 613-369-4784 representing Defendants(Janssen/Millennium) Kiernan Murphy 613-786-0273 representing Patentee/USA Comments: The defendant's motion for bifurcation will be heard at a special sitting on January 7, 2016 for 1/2 day in Ottawa. Briefing of the motion materials will be set out in the Court's Order to be issued. Minutes of Hearing entered in Vol. 938 page(s) 135 - 139 Abstract of Hearing placed on file
Covering letter from Plaintiff dated 30-SEP-2015 concerning Doc. Nos. 14 15 placed on file on 30-SEP-2015
Solicitor's certificate of service on behalf of Jeffrey Warnock confirming service of doc. #14 upon Plaintiff by by hand on 30-SEP-2015 confirming service doc. #14 upon Patentee by by hand on 30-SEP-2015 filed on 30-SEP-2015
Reply and Defence to Counterclaim on behalf of Plaintiff Filed on 30-SEP-2015
Oral directions received from the Court: Mireille Tabib, Prothonotary dated 22-SEP-2015 directing that A case management telephone conference will be held at 3:30p.m. on October 7, 2015. placed on file on 22-SEP-2015 Confirmed in writing to the party(ies)
Communication to the Court from the Registry dated 21-SEP-2015 re: Defendant's joint letter re: proposed draft schedule/CMC dates/issues re: Protective Order required and motion for bifurcation to be filed
Letter from Defendant dated 21-SEP-2015 enclosing a draft schedule to which all parties have consented. In addition, parties will require a Protective Order...and expect to come to an agreement on the terms of such an order. Furthermore, parties expect that they will not be able to reach an agreement with respect to bifurcation of the proceeding...and will bring a motion under Rule 107 in relation to Teva's claim...Lastly, Janssen and Millennium are requesting an expeditious trial date in this matter, preferably in 2 years. Parties are available for a CMC September 22 (except between 1-2), October 1 (after 12pm), October 5 (after 12pm), October 6(except between 1-2pm) and October 7 (after 12pm). received on 21-SEP-2015
Oral directions received from the Court: Mireille Tabib, Prothonotary dated 15-SEP-2015 directing that Re: Plaintiff's request on consent for an extension of time to provide the proposed schedule and CMC dates 'Extension is granted to September 21, 2015.' placed on file on 15-SEP-2015 Confirmed in writing to the party(ies)
Communication to the Court from the Registry dated 15-SEP-2015 re: Letter dated Sept. 11th requesting an ectension of time to provide their proposed timetable
Letter from Plaintiff dated 11-SEP-2015 requesting an extension of time until September 21, 2015 to provide a proposed timetable received on 11-SEP-2015
Oral directions received from the Court: Mireille Tabib, Prothonotary dated 02-SEP-2015 directing that The time within which Teva is to serve and file its Reply and Defence to Counterclaim is extended to September 30, 2015. placed on file on 02-SEP-2015 Confirmed in writing to the party(ies)
Communication to the Court from the Registry dated 01-SEP-2015 re: Plaintiff's letter seeking an extension of 30 days to file Teva's Reply and Defence to Counterclaim, on cosnent of the Def/Plain by Counterclaim
Letter from Plaintiff dated 28-AUG-2015 requesting an extension of 30 days (until Sept. 30) for service and filing of Teva's Reply and Defence to Counterclaim...on consent of the Defendants/ Plaintiffs by Counterclaim... received on 28-AUG-2015
Certificate of Transmission of Masud Husain, Direction - Criminal, Security and Diplomatic Law Division, Foreign Affairs, Trade and Development Canada of the Statement of Defence and Counterclaim on the Department of State of the United States of Americ on August 25, 2015 pursuant to subsection 9(5) of the State Immunity Act placed on file on 27-AUG-2015
Letter from Masud Husain, Director-Criminal,Security and Diplomatic Law Division - FATDC dated 25-AUG-2015 to confirm that the law firm of Borden Ladner Gervais LLP requested on July 31, 2015 service on the Government of the United States of America under the State Immunity Act in accordance with article 9 of the Act for the Statement of Defence and Counterclaim. A certificate of transmission is enclosed. received on 27-AUG-2015
Oral directions received from the Court: Mireille Tabib, Prothonotary dated 26-AUG-2015 directing that "The parties are to consult with each other and provide the Court, by September 14, 2015, with a proposed schedule for the next steps to be taken herein, as well as counsel's mutual dates of availability for a case management telephone conference should the Court wish to convene one." placed on file on 26-AUG-2015 Confirmed in writing to the party(ies)
Communication to the Court from the Registry dated 21-AUG-2015 re: Newly case managed file (s.8 claim for damages under PM(NOC)Regulations)
Proof of transmission by fax received from all parties with respect to Doc. no. 13 (Order from CJC dated 11aug2015) placed on file on 11-AUG-2015
Order dated 11-AUG-2015 rendered by Chief Justice Crampton Matter considered without personal appearance The Court's decision is with regard to Status Review Result: IT IS ORDERED pursuant to Rule 383 that Prothonotary Mireille Tabib is assigned as Case Management Judge in this matter. Filed on 11-AUG-2015 certified copies sent to parties Transmittal Letters placed on file. entered in J. & O. Book, volume 1274 page(s) 449 - 450 Interlocutory Decision
Covering letter from Plaintiff dated 31-JUL-2015 concerning Doc. No. 11 placed on file on 31-JUL-2015
Solicitor's certificate of service on behalf of Beverley Moore confirming service of the Statement of defence and counterclaim upon all parties by by hand and by courier on 31-JUL-2015 filed on 31-JUL-2015
Defence and Counterclaim filed on 31-JUL-2015
Covering letter from Plaintiff dated 16-JUL-2015 concerning Doc. Nos. 9 10 placed on file on 16-JUL-2015
Solicitor's certificate of service on behalf of Jeffrey Warnock confirming service of the Amended Statement of claim upon Defendant by telecopier on 16-JUL-2015 filed on 16-JUL-2015
Amended Statement of Claim filed on 16-JUL-2015
Letter from Defendant dated 15-JUL-2015 withdrawing the motion doc. 3 which was adjourned sine die received on 15-JUL-2015
Communication to the Court from the Registry dated 14-JUL-2015 re: sent to the Office of the Chief Justice for consideration of the parties' request for the assignment of a Case Management Judge
Acknowledgment of Receipt received from all parties (by e-mail) with respect to the Direction of the Court dated 13-JUL-2015 placed on file on 14-JUL-2015
Letter from Plaintiff dated 13-JUL-2015 requesting that the motion be adjourned on consent of all parties as they are trying to settle the issues raised in the motion. The parties also request the assignment of a case management Judge. received on 13-JUL-2015
Correction to General Sitting concerning Motion Doc. No. 3 Hearing removed from General Sitting at Ottawa on 15-JUL-2015 Reason for correction: Pursuant to the Direction dated 13-JUL-2015
Oral directions received from the presiding judge dated 13-JUL-2015 directing that "On consent the motion to strike a portion of the Statement of Claim is adjourned sine die. The request for special case management is referred to the office of the Chief Justice for consideration." placed on file on 13-JUL-2015 Confirmed in writing to the party(ies)
Covering letter from Defendants dated 09-JUL-2015 concerning Doc. 7 and Book of Authorities placed on file on 09-JUL-2015
Affidavit of service of Dawn Simpson sworn on 09-JUL-2015 on behalf of Defendants confirming service of the Defendant's Motion Record and Book of Authorities upon Plaintiff by personal service on 09-JUL-2015 filed on 09-JUL-2015
Book of Authorities consisting of 1 volume(s) on behalf of Defendants received on 09-JUL-2015
Motion Record containing the following original document(s): 3 4 5 6 Number of copies received: 3 on behalf of Defendants filed on 09-JUL-2015
Written Representations contained within a Motion Record on behalf of Defendants concerning Motion Doc. No. 3 filed on 09-JUL-2015
Affidavit of Dr. Karoline Shair sworn on 09-JUL-2015 contained within a Motion Record on behalf of Defendants in support of Motion Doc. No. 3 filed on 09-JUL-2015
Affidavit of Angela Malcolm sworn on 09-JUL-2015 contained within a Motion Record on behalf of Defendants in support of Motion Doc. No. 3 with Exhibits 1 filed on 09-JUL-2015
Notice of Motion contained within a Motion Record on behalf of Defendants returnable at General Sitting in Ottawa on 15-JUL-2015 to begin at 09:30 duration: 1h language: E for 1. An Order striking the phrase "or an earlier date as determined by the Court" from paragraph 20 of Teva Canada Limited's Statement of Claim; 2. In the alternative, an Order for particulars of the allegation of an "earlier date" from paragraph 20 of Teva's Statement of Claim; 3. An Order extending the time within which the Defendants are required to file their Statement of Defence and Counterclaim to a date 15 days after the within motion has been decided, or, if particulars are ordered, to a date upon which particulars have been provided; 4. Millennium's costs of this motion; and 5. Such further and other relief as this Honourable Court may deem just. filed on 09-JUL-2015
Affidavit of service of David Nernell sworn on 09-JUN-2015 on behalf of Plaintiff confirming service of Statement of Claim doc.01 upon Defendant by personal service on 09-JUN-2015 filed on 09-JUN-2015
Statement of Claim filed on 05-JUN-2015 Tariff other action - $150.00
The official version of the court proceeding information is available from the court websites directly: